Disruption of Cell-Cell Adhesion Codes Underlies the Unique X-linked Inheritance Pattern of Protocadherin 19 Girls Clustering Epilepsy by Pederick, Daniel Tyler
 
  
Disruption of Cell-Cell Adhesion Codes 
Underlies the Unique X-linked 
Inheritance Pattern of Protocadherin 19 




Daniel Tyler Pederick                                                                                                          
B.Sc. (Biomedical Science), Honours (Biochemistry) 
A thesis submitted in fulfilment of the requirements for the degree of Doctor 
of Philosophy 
Department of Molecular and Cellular Biology 
School of Biological Science 






Abstract ................................................................................................................................. iii 
PhD Thesis Declaration ......................................................................................................... v 
Publications ......................................................................................................................... viii 
Conference Oral Presentations .............................................................................................. ix 
Awards .................................................................................................................................. xi 
Introduction .......................................................................................................................... 12 
1.1 Epilepsy ...................................................................................................................... 13 
1.2 Protocadherin 19 Girls Clustering Epilepsy .............................................................. 16 
1.3 Pcdh19 expression in the mammalian brain .............................................................. 20 
1.4 The Cadherin Superfamily ......................................................................................... 22 
1.5 Adhesive Functions of Protocadherins in the Mammalian Brain .............................. 27 
1.6 Neural Function of PCDH19 ...................................................................................... 33 
1.7 What causes the unusual inheritance of PCDH19-GCE? .......................................... 35 
1.8 Pcdh19 Null Mouse.................................................................................................... 37 
1.9 Project Rationale ........................................................................................................ 38 
 
CHAPTER 2: Pcdh19 Loss-of-Function Increases Neuronal Migration In Vitro but is 
Dispensable for Brain Development in Mice ...................................................................... 39 
2.1 Summary .................................................................................................................... 40 
 
CHAPTER 3: Abnormal cell sorting is associated with the unique X-linked inheritance of 
PCDH19 epilepsy ................................................................................................................ 58 
3.1 Summary .................................................................................................................... 59 




CHAPTER 5: Future Directions ........................................................................................ 134 
5.1 Investigating Connectivity between PCDH19 WT and PCDH19 null neurons ....... 136 
5.2 Is Interneuron Distribution Affected by Mosaic Pcdh19 Expression?..................... 138 
5.3 Can Epileptiform Brain Activity be Rescued after Abnormal Cell Sorting has 
Occurred? ....................................................................................................................... 143 
5.4 Investigating the Combinatorial Activity of other NC PCDHs In Vivo ................... 144 
5.5 Concluding remarks ................................................................................................. 146 
 
Additional Methods............................................................................................................ 147 
 
















Epilepsy is a disease of the central nervous system (CNS) caused by increased neuronal 
activity resulting in seizures and often loss of consciousness. Epilepsy can result from both 
traumas to the brain or a genetic predisposition. Recent advances in DNA sequencing 
technology has identified many forms of epilepsy caused by mutations in single genes. 
Although such monogenic epilepsies are rare, investigating their underlying molecular 
mechanisms provides important insights into pathways and processes that cause seizures and 
assists in the application of pharmacotherapy and surgical strategies.  
The second most common form of monogenic epilepsy is Protocadherin 19 Girls Clustering 
Epilepsy (PCDH19-GCE) caused by mutation of the X-linked gene PCDH19. This disorder 
is characterised by clusters of febrile seizures beginning in early childhood that is often 
accompanied by variable intellectual disability and autism spectrum disorder. The most 
striking feature of PCDH19-GCE is its unique X-linked inheritance pattern; heterozygous 
females with PCDH19 mutations are affected whereas hemizygous males are not. It is 
hypothesised that the mixture of PCDH19-WT and PCDH19-mutant neurons (generated by 
random X-inactivation in female brains) causes abnormal neuronal connections leading to 
disease. However, there is no experimental evidence supporting this hypothesis and the 
cellular and molecular mechanisms underpinning this unique inheritance pattern are 
unknown.  
To better understand how mutation of PCDH19 leads to the unique X-linked inheritance 
pattern this thesis uses a Pcdh19 null mouse, cell culture assays and unique CRISPR-Cas9 
engineered mouse models. It is shown that heterozygous and homozygous deletion of 




null neurons are present within the correct layers in the cortex despite their slight increase in 
migration potential in vitro. 
Using cultured K562 cells it is shown that PCDH19 and other non-clustered (NC) PCDH 
members contribute to combinatorial adhesion codes that dictate specific cell-cell 
interactions. Similarly, mosaic expression of Pcdh19 in heterozygous mice leads to abnormal 
cell sorting in the developing cortex such that cells separate into PCDH19 positive and 
negative patches, correlating with altered brain network activity consistent with changes that 
can underlie seizures in adult mice. Deletion of Pcdh19 in heterozygous embryos using 
CRISPR-Cas9 technology eliminates this incompatibility of adhesion codes and prevents 
abnormal cell sorting from occurring. In addition, variable cortical folding malformations in 
PCDH19-GCE epilepsy patients were identified.  Collectively these results highlight the role 
of PCDH19 in determining specific adhesion codes during brain development and how 
disruption of these codes is associated with the unique X-linked inheritance pattern of 
PCDH19-GCE. Importantly, a framework is provided for investigating how this abnormal 
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Epilepsy is a neurological disease caused by a combination of genetic and environmental 
factors and with 3-4% of the population developing the disorder at some stage in their life 
this presents a serious burden to society. It is primarily defined by recurrent seizures and 
while anti-epileptic drugs are an effective treatment for many patients, up to 30% of epilepsy 
cases are drug refractory. Epileptic seizures can be the result of a genetic predisposition or a 
structural abnormality in the brain e.g. a tumour or trauma. Seizure types can vary and are 
important in classifying and managing an individual’s epilepsy. Partial seizures are limited 
to only one region of the brain and can be termed “simple” if there is no loss of consciousness 
and “complex” if consciousness is lost. Generalised seizures involve the whole brain and 
consciousness is normally impaired. There are six major types of generalized seizures; tonic-
clonic, absence, myoclonic, tonic, clonic and atonic. The characteristics of each seizure type 
vary depending on how they affect the neuronal networks in the brain. Understanding the 
normal neuronal networks in the brain and how epilepsy alters their function is essential to 
investigate the cause of epilepsy and for effective therapeutic intervention. 
Identifying the causes of different epileptic disorders is essential to provide key information 
that guides therapeutic treatment. Improvements in understanding the causes of epilepsy 
have largely been due to advances in DNA sequencing technology. In 1975 Hauser and 
Kurland estimated that the majority of epilepsy cases could be classified as “idiopathic” 
(unknown cause) (Hauser and Kurland, 1975). Today, the term idiopathic has been left 
behind and such cases are now thought to be monogenic syndromes (caused by mutation of 
a single gene) or more genetically complex disorders which may involve modified 
susceptibility loci (Figure 1-1) (Thomas and Berkovic, 2014).  
Although single gene epilepsies are rare, investigating and understanding their molecular 
causes provides important information regarding the molecular pathways and cellular 
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processes that are involved in causing or propagating seizures and in guidance for 
































Figure 1-1. The majority of epilepsy cases are thought to be caused by a genetic predisposition. 
Hauser and Kurland (1975) described most epilepsy cases as “idiopathic”. In recent years, with the 
advances in DNA sequencing technology, it is thought that cases previously described as idiopathic 





1975 (Hauser and Kurland)                                     2014 paradigm 
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1.2 Protocadherin 19 Girls Clustering Epilepsy 
PROTOCADHERIN 19 Girls Clustering Epilepsy (PCDH19-GCE; also known as Epilepsy 
and Mental Retardation limited to Females (EFMR)) is a female-specific condition caused 
by mutation in the X-linked gene PCDH19 (Dibbens et al., 2008; Ryan et al., 1997). The 
disorder is primarily defined by clusters of febrile seizures beginning in early childhood with 
variable intellectual disability and autism spectrum disorder (ASD) (Marini et al., 2010; 
Ryan et al., 1997; Scheffer et al., 2008). PCDH19-GCE is now recognised as the second 
most common monogenic epilepsy disorder behind Dravet syndrome (Duszyc et al., 2014; 
Marini et al., 2010). Symptoms in affected females vary from mild to severe, ranging from 
benign focal epilepsy with normal cognitive function to severe seizures and intellectual 
disability that resemble Dravet syndrome (Depienne and LeGuern, 2012; Scheffer et al., 
2008). Febrile seizures are the initial indicator in approximately half of all cases with seizure 
types mostly involving generalized tonic, clonic or tonic-clonic and or focal seizures (Marini 
et al., 2010).   
PCDH19-GCE exhibits a unique X-linked mode of inheritance (Ryan et al., 1997). X-linked 
diseases are usually characterized by affected males and unaffected carrier females (i.e. a 
recessive mode of inheritance). In contrast, PCDH19-GCE only affects heterozygous 
females, with transmitting hemizygous males showing normal cognitive function and no 
seizures (Figure 2-1) (Depienne and LeGuern, 2012; Fabisiak and Erickson, 1990; Juberg 






















Figure 2-1. PCDH19-GCE displays a unique X-linked inheritance pattern. Most X-linked 
disorders exhibit recessive inheritance in which hemizygous males are affected while heterozygous 
female carriers are not (left). In contrast, PCDH19-GCE affects heterozygous females, while 
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Recent analysis of PCDH19-GCE individuals by multiple research groups has identified 
over 100 mutations in the PCDH19 gene with both inherited and de novo mutations reported. 
These include nonsense mutations, nucleotide insertions and deletions, mutations altering 
the splice sites, missense mutations, intragenic and whole gene deletions (Figure 3-1) 
(Depienne and LeGuern, 2012). The majority of pathological disease mutations are nonsense 
and missense mutations positioned in exon 1, affecting highly conserved amino acids in the 
extracellular domain of PCDH19. PCDH19 mRNAs with premature stop codons have been 
shown to undergo nonsense mediated decay and together with identification of whole gene 
deletions this suggests that loss of function is the likely outcome from the mutations which 
has been confirmed through a series of bead aggregation assays (Cooper et al., 2016; 
Dibbens et al., 2008). Furthermore, there does not appear to be any correlation between the 
severity of the phenotype and the type of mutation i.e. the same mutation results in variable 
degrees of disease severity in different individuals (Depienne et al., 2011; Higurashi et al., 
2013; Scheffer et al., 2008). This is further highlighted by different phenotypes presented in 
























Figure 3-1. Schematic diagram highlighting the types and location of mutations leading to 
PCDH19-GCE. Over 100 unique disease mutations have now been identified, the most common 
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1.3 Pcdh19 expression in the mammalian brain 
Pcdh19 was first discovered in 2001 when its mRNA expression was reported in multiple 
tissues (Wolverton and Lalande, 2001). Pcdh19 expression is tightly controlled both 
spatially and temporally within the central nervous system during mammalian development 
(Figure 4-1) (Dibbens et al., 2008; Gaitan and Bouchard, 2006). In situ hybridisation of WT 
Pcdh19 in mice indicates widespread expression in both the embryonic and postnatal CNS 
including the cortex, hippocampus, retina, nasal epithelium and spinal cord (Dibbens et al., 
2008; Gaitan and Bouchard, 2006). Pcdh19 is highly expressed in the sub-ventricular zone, 
intermediate zone, sub-plate, hippocampus, specific layers (II, IV, V and VI) of the cerebral 
cortex and the subiculum. Expression in these specific regions suggests important functional 
roles in neuronal development as well as potential roles in the formation of neuronal 
























Figure 4-1. Pcdh19 expression is widespread in the developing and postnatal mouse CNS. c) 
High Pcdh19 mRNA levels were observed in multiple brain regions of sagittal 12.5 dpc embryo 
sections. di, diencephalons; dmes, dorsal mesentery; ep, epiphysis; oe, olfactory epithelium; sc, 
spinal cord. Scale bar 500 μm. Adapted from Gaitan and Bouchard (2006). g,h) Adjacent coronal 
section through the mid-hippocampal region stained with haematoxylin and eosin and processed for 
Pcdh19 in situ respectively. i) a more posterior brain section to h, showing Pcdh19 expression. j-l) 
Higher-magnification images of the boxed regions in g and h. Arrowheads in j and k showing Pcdh19 
expression within cortical layers II-IV. Cx-cortex. Scale bars in a,b,f-I 200μM, in c-e, j-I 50μM. 
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1.4 The Cadherin Superfamily 
To comprehend how mutation of PCDH19 leads to human disease it is important to 
understand its normal function. PCDH19 is a member of the protocadherin family, a 
subgroup of the cadherin superfamily.  
 
Cadherins are calcium-dependent cell-cell adhesion molecules that play major roles in 
development, tissue morphogenesis, maintaining structural integrity of solid tissues and 
regulating turnover and reorganization of tissue structures (Gumbiner, 1996, 2005; Hatta and 
Takeichi, 1986; Hatta et al., 1988; Leckband and Prakasam, 2006; Patel et al., 2003; 
Takeichi, 1995; Takeichi et al., 1981). They are single-pass transmembrane proteins defined 
by multiple cadherin repeat sequences in their extracellular domain which mediate 
homotypic cell-cell adhesion. The links between these repeats are made more rigid and 
strengthened by the specific binding of Ca2+ ions (Boggon et al., 2002; Nagar et al., 1996). 
The intracellular domains of the different cadherins are variable, allowing different 
functional roles for each cadherin. 
Cadherins are divided into three major subfamilies, the classical cadherins, desmosomal 
cadherins and the protocadherins (Figure 5-1). Classical cadherins were the first group to be 
discovered and can be split into two subfamilies; Type 1 and Type 2. They have common 
features such as five extracellular cadherin repeats and conserved cytoplasmic domains that 
interact with cytoskeletal proteins, most importantly α- and β-catenin. Absence of α- or β-
catenin leads to defective cell-cell adhesion and failure of cadherin-catenin complexes to 
associate with the actin  
 
 















Figure 5-1. Cadherins are divided into three main subgroups. Variation occurs in the number of 
extracellular cadherin repeats present as well as the interaction domains in the cytoplasmic regions. 
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cytoskeleton (Hatta and Takeichi, 1986; Pettitt, 2005). Type 1 classical cadherins contain an 
extracellular tryptophan residue (W2) and a corresponding hydrophobic pocket in the 
cadherin repeat sequence, while type 2 classical cadherins contain two conserved tryptophan 
residues (W2 and W4) and two hydrophobic pockets. The conserved tryptophan residues 
and hydrophobic pockets are critical for both homodimerization and cell-cell adhesion 
(Boggon et al., 2002). Desmosomal cadherins are highly similar to type 1 classical cadherins 
but contain 4 extracellular repeats and have a different cytoplasmic domain allowing 
connection to intermediate filaments. It is suggested that desmosomal cadherins are required 
for strong cell-cell adhesion but is unclear whether this is primarily due to homophilic or 
heterophilic interactions (Delva et al., 2009).  
Protocadherins are structurally similar to classical cadherins however the conserved 
tryptophan residues are replaced with two cysteine residues that are thought to perform a 
similar function (Morishita et al., 2006). Currently more than 70 protocadherin genes have 
been identified, making up the largest subgroup of the cadherin family. Protocadherins are 
divided into two groups based on their genomic arrangement: clustered and non-clustered 
(Figure 6-1). Clustered protocadherins are grouped within the genome, encoding 58 
transcripts from only three gene clusters located on the same chromosome. Non-clustered 
protocadherins are scattered throughout the genome and can be divided into two groups 
PCDHδ and “other” protocadherins.  Clustered protocadherins have six extracellular 
cadherin repeats while members of the non-clustered family have between four and seven 
cadherin repeats (Kim et al., 2011; Morishita and Yagi, 2007; Redies et al., 2005). There are 
nine PCDHδ members, all of which contain two highly conserved regions (CM1 and CM2) 
 
 














Figure 6-1. Clustered PCDHs consist of the α, β and γ subfamilies. Non-clustered PCDHs are 
divided into two groups, PCDHδ family and other PCDHs. PCDHδ members are further 
categorized by the presence/absence of a third highly conserved extracellular domain. Adapted from 
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in their cytoplasmic domains (Morishita and Yagi, 2007). The PCDHδ family can be further 
divided into two subgroups depending on; overall homology, number of EC repeats present 
and conservation of specific amino acids within the cytoplasmic domain (Figure 6-1). The 
PCDHδ1 subgroup consists of Pcdh-1, 7, 9 and 11, and the PCDHδ2 subgroup contains 
PCDH-8, 10, 17, 18 and 19 (Morishita and Yagi, 2007). While the extracellular domain of 
protocadherins is essential for homotypic cell-cell interactions (Morishita and Yagi, 2007; 
Patel et al., 2003; Redies et al., 2005; Yagi and Takeichi, 2000) the cytoplasmic domains of 
protocadherins are structurally diverse and may have the ability to form novel interactions. 
 
Overall PCDHs have homotypic adhesion function which is regulated through the 
extracellular domains, in contrast to the intracellular domains which are variable amongst 
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1.5 Adhesive Functions of Protocadherins in the Mammalian Brain 
Protocadherins have been reported to be implicated in many different processes within the 
CNS including neuronal migration, organisation of different neuronal populations, 
synaptogenesis, ectoderm differentiation, neuronal self-avoidance, cytoskeletal changes and 
cell differentiation (Frank and Kemler, 2002; Hoshina et al., 2013a; Junghans et al., 2005; 
Lefebvre et al., 2012; Morishita and Yagi, 2007; Redies et al., 2005).  
 
In recent years the adhesive function of clustered PCDHs has been proposed to be crucial 
for neuron identification of self from non-self within the mammalian brain, similar to the 
function of DSCAM genes in Drosophila (Soba et al., 2007). Deletion of clustered Pcdhγ 
genes disrupts the self-avoidance of neuronal processes in retinal starburst amacrine cells 
and Purkinje cells (Figure 7-1A, left) (Lefebvre et al., 2012). Furthermore replacement of 
the deleted Pcdhγ cluster with a single Pcdhγ isoform restores self-avoidance suggesting that 
homophilic adhesion interactions between neurites from the same neuron generate a 
repulsive signal leading to self-avoidance (Figure 7-1A, right)  (Lefebvre et al., 2012). It has 
been proposed that interactions between different neurons are allowed to occur as dendrites 
will rarely encounter a matched set of clustered PCDHs, unless they originate from the same 
soma (Lefebvre et al., 2012). Therefore, it is crucial that each neuron in the brain expresses 
a unique combination of clustered PCDHs which is supported by the random expression 
pattern of clustered PCDHs which is dependent on cis regulatory elements that determine 
which members of the clusters are to be expressed (Ribich et al., 2006; Yokota et al., 2011). 
For example, Purkinje cells express ~2 of the 5’ 12 Pcdhα isoforms, ~4 of the 5’ 19 Pcdhγ 
members and ~4 of the 22 Pcdhβ isoforms while the 3’ members of the α and γ clusters are 
expressed constitutively in all Purkinje cells (Yagi, 2012). This random pattern of expression 
in  


































Figure 7-1. Clustered PCDHs have a functional role in neuronal self-avoidance which is 
thought to arise by dictating specific interactions between cells. A) Deletion of all Pcdhγ 
members in starburst amacrine cells leads to increased amount of “self” interactions. This can be 
rescued by the expression of a single PCDHγ protein in PCDHγ null star amacrine cells. Adapted 
from Lefebvre et al. (2012) B) K562 cells expressing the same clustered PCDH combinations display 
extensive mixing. In contrast, mixing cells expressing different clustered PCDH combinations results 
in segregation of green and red cells. Adapted from Thu et al. (2014). C) A model for PCDH mediated 
cell-cell recognition based on lattice-like structures. A single mismatch of PCDH isoforms between 
cells terminates chain extension. It is proposed that interaction of clustered PCDHs leads to an 
avoidance event through an intracellular signalling. A repulsion signal is only achieved through the 
formation of extensive PCDH lattice molecules. Mathematical modelling predicts that the size of the 
PCDH lattice-like complex is dramatically reduced with just one PCDH mismatch between cells. 
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Purkinje cells suggests that almost every neuron in the brain will contain a different profile 
of clustered PCDH expression (Yagi, 2012). 
 
The molecular logic of how clustered PCDHs determine self-avoidance has been 
investigated through a series of cell aggregation and structural modelling experiments 
(Goodman et al., 2016; Nicoludis et al., 2015, 2016; Rubinstein et al., 2015; Schreiner and 
Weiner, 2010; Thu et al., 2014). Using K562 cells (which express no classical cadherins or 
PCDHs) it was shown that homophilic interactions between different combinations of 
clustered PCDHs are dependent on all isoforms expressed, such that a single mismatched 
isoform disrupts adhesion of cells (Figure 7-1B) (Rubinstein et al., 2015; Schreiner and 
Weiner, 2010; Thu et al., 2014). Structural studies by multiple groups revealed that EC1-
EC4 domains are critical for homophilic trans binding of PCDHs between adjacent cells and 
that the EC6 domain is essential for heterophilic cis interactions of different PCDHs within 
the same cell (Goodman et al., 2016; Nicoludis et al., 2015, 2016; Rubinstein et al., 2015). 
Rubinstein et al (2015) proposed a model whereby clustered PCDHs form cis heterodimers 
that engage in a head-to-tail homophilic trans interaction across two cells that form a zipper-
like structure. When two neurites from the same cell interact large zipper-like PCDH 
complexes will form and lead to repulsive downstream signalling, but if two neurites from 
different cells interact the zipper-like structure will terminate due to the mismatch in PCDHs 
providing a size dependent mechanism for self-avoidance (Figure 7-1C) (Rubinstein et al., 
2015). It is thought that only large lattice structures will generate sufficient avoidance 
signalling to cause neurite repulsion, in contrast to smaller mismatched lattice structures 
where the avoidance signalling will be below the repulsion threshold.  
The homophilic function of Pcdhγ isoforms has also been shown to regulate synapse 
formation between distant neurons and deletion of the Pcdhγ cluster in cortical and 
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hippocampal neurons leads to simplified dendritic arbors (Garrett et al., 2012; Kostadinov 
and Sanes, 2015; Suo et al., 2012). Furthermore, the homotypic adhesive function of Pcdhγ 
molecules promotes dendritic arborisation at local sites between neurons and between 
neurons and astrocytes (Molumby et al., 2016). 
 
The degree of functional overlap between clustered and non-clustered PCDHs is unclear and 
in particular whether PCDH19 and other non-clustered PCDHs act combinatorially has not 
been addressed. Combinatorial activity of non-clustered PCDHs may be possible given that 
the expression of non-clustered PCDHs spatially overlap in the developing and postnatal rat 
CNS and individual neurons in the mouse somatosensory cortex have been shown to express 
multiple non-clustered PCDH molecules (Figure 8-1) (Kim et al., 2007, 2010; Krishna-K et 
al., 2011). Furthermore in vitro bead assays showed that PCDH19 interacts with N-cadherin 
(N-CAD) to form a novel adhesion complex that cannot form trans interactions with 
PCDH19 or N-CAD alone (Emond et al., 2011). This is reminiscent of the combinatorial 
activity of the clustered PCDHs and supports the potential for PCDH19 to interact with 
adhesion molecules including non-clustered PCDHs to form combinatorial adhesion 
specificity.  
Additionally, the non-stochastic nature of non-clustered PCDH expression suggests that 
combinatorial adhesive codes dictated by this group of molecules will play roles in guiding 
neurons to coalesce/form connections with other appropriate neurons, rather than providing 
























Figure 8-1. Non-clustered PCDHs display overlapping expression in the developing and 
postnatal rodent cortex.  A) In situ hybridisation of rat embryos displays overlapping expression of 
many non-clustered PCDHs in the CNS. Adapted from (Kim et al., 2007).  B) Double fluorescent in 
situ hybridisation of the mouse somatosensory cortex shows that multiple non-clustered PCDHs are 
expressed within the same neuron. Adapted from Krishna-K et al. (2011).  
A 
B 
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1.6 Neural Function of PCDH19 
To date the endogenous function of PCDH19 has not been investigated in a mammalian 
brain, primarily being limited to studies performed in vitro and using the model organism 
Danio rerio (zebrafish). 
Cell culture assays have been utilised to show PCDH19 can cause calcium dependent cell 
aggregation (Tai et al., 2010). Additionally, cells expressing PCDH19 were labelled and 
mixed with cells expressing PCDH10 and both populations formed aggregates 
predominantly containing either PCDH19 or PCDH10 cells, confirming the homotypic 
adhesion function of PCDH19 (Tai et al., 2010). The function of endogenous PCDH19 has 
been investigated in zebrafish using knock down and knock out approaches (Cooper et al., 
2015; Emond et al., 2009). Unfortunately, these studies provided conflicting results making 
it difficult to interpret the role of PCDH19 in the CNS. Morpholino injections targeting 
pcdh19 resulted in a significant knockdown of pcdh19 gene expression (Emond et al., 2009). 
Morphant embryos exhibited a misfolded midbrain-hindbrain region compared to wild type 
embryos at 28 hours post fertilisation. At the 10 somite stage pcdh19 morphants exhibited 
malformations of the anterior neural rod, displayed impaired convergent cell movements in 
the lateral plate and a significantly wider neural plate. Knockdown of pcdh19 also resulted 
in cell motility defects in the anterior neural plate including a decrease in the directional 
specificity and a reduced level of coupled migration with neighbouring cells. A second study 
deleted pcdh19 in zebrafish using TALEN genome editing technology (Cooper et al., 2015). 
In contrast to the above mentioned study, Pcdh19 null zebrafish were viable and fertile and 
did not display any defects in neural plate morphology. However, disruption of columnar 
organisation in the optic tectum was observed leading to defects of visually guided 
behaviours. These data suggest a role for Pcdh19 in organisation of the developing nervous 
system. However, the conflicting phenotypes resulting from knock down versus knock out 
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experiments makes it difficult to interpret the endogenous role of Pcdh19 in the mammalian 
brain and to gain insight into how mutation leads to disease.       
The adhesive roles of multiple non-clustered PCDHs in the mammalian brain have been 
investigated using genetically modified mice (Hayashi et al., 2014; Hoshina et al., 2013b; 
Uemura et al., 2007; Yamagata et al., 1999; Yasuda et al., 2007). Pcdh17 null mice have 
been shown to have defects in both the regulation of presynaptic assembly in corticobasal 
ganglia circuits and abnormalities in axon projections from the amygdala to the 
hypothalamus (Hayashi et al., 2014; Hoshina et al., 2013a).  Similarly, Pcdh10 deficient 
mice have defects in axonal pathways through the ventral telencephalon (Uemura et al., 
2007). Studies of Pcdh7 and Pcdh8 in mice have revealed their roles in retinal ganglion cell 
dendrite arborisation and disruption of axonogenesis and the regulation of dendritic spine 
density and synaptogenesis, respectively (Leung et al., 2013; Piper et al., 2008). The 
cytoplasmic domains of PCDH17, PCDH10 and PCDH8 are also likely to play a role in axon 
guidance as they have been shown to interact with the WAVE regulatory complex which 
controls actin cytoskeletal dynamics (Chen et al., 2014). PCDH19 has also been reported to 
interact with WAVE complex proteins and therefore could also be implicated in the process 
of axon guidance (Chen et al., 2014). 
As non-clustered PCDHs are highly conserved amongst members these studies provide us 
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1.7 What causes the unusual inheritance of PCDH19-GCE? 
The most striking characteristic of PCDH19-GCE is its unique pattern of X-linked 
inheritance. This feature is poorly understood as current model organism studies have been 
limited to zebrafish where pcdh19 is positioned on chromosome 14. To date multiple 
theories have been proposed to explain the unique pattern of inheritance but there is a lack 
of supporting evidence.   
Given that males with PCDH19 mutations (hemizygous) do not develop seizures and have 
normal cognitive function, it is suggested that the complete loss of PCDH19 is not 
pathogenic. On the other hand, females with one wild type and one mutated allele of 
PCDH19 (heterozygous) are affected. Therefore it was initially proposed that PCDH19 
mutations were dominant negative, but the identification of whole gene deletions and cases 
of nonsense mediated decay provided strong evidence opposing this hypothesis (Dibbens et 
al., 2008). It was also suggested that males may be able to compensate for the loss of 
PCDH19 through the Y-linked PCDH11Y. However, this has also been ruled out due to the 
discovery of several mosaic males with early somatic mutations in PCDH19, that phenocopy 
affected girls with heterozygous mutations (Depienne et al., 2009; Terracciano et al., 2016). 
The current withstanding hypothesis proposes that the coexistence of WT and mutant 
PCDH19 neurons arising through random X-inactivation underlie the unique pattern of 
inheritance (Figure 9-1) (Depienne et al., 2009; Dibbens et al., 2008).  It is suggested that 
this mosaicism leads to abnormal neuronal connections between PCDH19 WT and PCDH19 
mutant cells affecting neural network formation. However, it remains to be determined how 
mosaicism could lead to PCDH19-GCE at the molecular, cellular and network level.  
Furthermore, this is unable to explain how the complete absence of PCDH19 does not result 
in epilepsy.   
 

















Figure 9-1. PCDH19-GCE is proposed to be caused by abnormal connections between PCDH19 
positive and PCDH19 negative neurons. A) Normal individuals will have one population of 
PCDH19 containing cells and will be able to form proper neural networks. B) Similarly, hemizygous 
males will have population of PCDH19 negative cells and will form normal neuronal connections 
like normal individuals. C) Heterozygous females have two populations of cells, PCDH19 positive 
and PCDH19 negative, which cannot interact with each other to form appropriate neural networks, 
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1.8 Pcdh19 Null Mouse  
Genetically manipulated mice are commonly used to understand how genetic mutations 
contribute to disease phenotypes. By knocking in or knocking out genes implicated in 
disease the functional role proteins play in disease and the phenotype can be studied, leading 
to better understanding of the disease and potential new treatments for humans. 
As Pcdh19 is also X-linked in mice a suitable approach to investigate to the cellular and 
molecular basis of PCDH19-GCE would be to generate a mouse model in which Pcdh19 is 
mutated to mimic a human PCDH19-GCE mutation. However, this approach assumes that 
the pathogenic mechanism underpinning PCDH19-GCE is conserved in mouse and human.  
Epilepsy has an obvious seizure phenotype providing an accessible target to study as a 
complex trait in experimental animal models. Several examples of laboratory mice exist that 
model epilepsy, including Cntnap2 deficient mice, which model temporal lobe epilepsy 
(Buckmaster and Lew, 2011; Peñagarikano et al., 2011). Spontaneous mouse models of 
epilepsy also exist in the form of DBA mice which experience severe tonic-clonic seizures 
in response to audiogenic stimuli (Hall, 1947) and the EL mouse strain which has limbic and 
tonic-clonic convulsions that are induced by routine animal handling (Rise et al., 1991; 
Suzuki and Yurie, 1977).  
With this in mind we acquired a potential disease mouse model for PCDH19-GCE. Lexicon 
Pharmaceuticals engineered a mouse where exon 1,2 and 3 of the Pcdh19 gene are replaced 
with a β-galactosidase/neomycin fusion cassette as selection markers. Exon 1, 2 and 3 
encode the entire extracellular and transmembrane region so by deleting these regions it 
should result in loss of PCDH19 function. Since it is thought that PCDH19-GCE mutations 
are loss-of-function it was hypothesised that the Pcdh19 mutant mouse could be used to 
model PCDH19-GCE and gain insight into the cellular and molecular cause of the disease.   
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1.9 Project Rationale 
PCDH19 is a homotypic cell-cell adhesion molecule, which when mutated causes epilepsy 
and cognitive impairment in humans. PCDH19-GCE has a unique X-linked inheritance 
pattern whereby heterozygous females are affected and hemizygous males are not. It has 
been proposed that abnormal neuronal interactions occur between PCDH19 WT and 
PCDH19 mutant cells in the brain of heterozygous females leading to disease. However, the 
molecular and cellular mechanism causing disease is unknown. Furthermore, it is not 
understood how the complete absence of PCDH19 in hemizygous males does not lead to 
pathology. These are the key questions that will be investigated in the research of this thesis, 
with the aims of: 
 
1. Characterising the endogenous function of PCDH19 in the mammalian brain. 
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Using cultured cell assays PCDH19 has been shown to have weak homotypic cell-cell adhesion 
activity, interact with N-cadherin to form novel adhesion complexes and interact with various 
members of the WAVE complex (Emond et al., 2011; Tai et al., 2010). To understand the 
endogenous role of PCDH19 in the CNS the majority of studies have used zebrafish as a model 
organism. Two independent studies using morpholino knockdown of pcdh19 or TALEN 
mediated null zebrafish gave severe and mild phenotypes, respectively (Cooper et al., 2015; 
Emond et al., 2009). These conflicting data make it difficult to interpret the endogenous 
function of PCDH19 in the CNS. Furthermore, the endogenous role of PCDH19 in the 
mammalian brain has yet to be investigated and therefore was addressed in the paper presented 
in this chapter entitled “Pcdh19 Loss-of-Function Increases Neuronal Migration In Vitro but is 
Dispensable for Brain Development in Mice”. 
In this paper we validated the first Pcdh19 null allele in mice confirming the expression of 
PCDH19 protein in the hippocampus, cortex and cerebellum. We also showed that the β-
Galactosidase/Neomycin reporter allele, marking Pcdh19 null cells, was expressed in the same 
brain regions. We confirmed the expression of PCDH19 in the synapses of hippocampal 
neurons and ruled out the presence of gross morphological defects in the brains of Pcdh19 
heterozygous and homozygous null mice. We also showed that Pcdh19 null cells were not 
ectopically located in the developing and postnatal brains of Pcdh19 heterozygous and 
homozygous null mice. Furthermore, we showed a subtle increase in neuronal migration 
potential of Pcdh19 null cells in vitro although this did not translate to overt positional changes 
of neurons in the developing and adult mouse brain. While further detailed analysis of this 
mouse model may reveal subtle defects in Pcdh19 null mouse brains, overall we show that 
despite widespread expression of Pcdh19 in the CNS, deletion of Pcdh19 does not grossly 
affect brain develop
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The most intriguing characteristic of PCDH19-GCE is its unique pattern of X-linked 
inheritance. To date there is no experimental evidence providing insight into the molecular 
and cellular mechanisms underlying the unique inheritance. Therefore, this was addressed 
in the submitted manuscript presented in this chapter entitled “Abnormal cell sorting is 
associated with the unique X-linked inheritance of Protocadherin 19 epilepsy”. 
To begin investigating the cellular mechanism that underlies the unique X-linked inheritance 
of PCDH19-GCE we used an in vitro system to investigate the role of PCDH19 in dictating 
specific cell-cell interactions and how disease causing missense mutations impact normal 
function. K562 cells were used to perform these experiments as they do not express 
endogenous protocadherins or classical cadherins (Ozawa and Kemler, 1998; Schreiner and 
Weiner, 2010), meaning all cell-cell interactions we observed were dependent on the PCDHs 
we exogenously expressed.  
Two populations of cells co-expressing the same combination of NC PCDHs displayed 
extensive mixing but when one of these populations had a NC PCDH deleted, added or 
substituted, the two cell populations displayed significant sorting into two groups dependent 
on the NC PCDHs they expressed. We also performed aggregation assays using K562 cells 
and confirmed that three disease causing missense mutations lack adhesive activity. We next 
mixed cells expressing WT PCDH19/PCDH10 with mutant PCDH19/PCDH10 and 
observed significant segregation of the two cell populations. These experiments provide the 
first evidence that NC PCDHs can cooperate to determine adhesion specificities which are 
sensitive to single PCDH differences. 
Next, we sought to investigate how perturbation of these adhesion codes would manifest in 
the developing mammalian brain where complex arrays of adhesion molecules direct 




morphogenesis. We showed that young adult heterozygous mice display abnormally 
elevated neuronal activity and that this phenotype is not present in homozygous mice, 
consistent with the unique X-linked inheritance of PCDH19-GCE in humans.  
 
To determine the impact of mosaic PCDH19 expression at the cellular level in vivo we 
required reporter alleles for Pcdh19-expressing WT and null cells. To label Pcdh19 null 
cells, we used the previously validated Pcdh19 null mice from Chapter 2. In Chapter 3 we 
describe the generation of a mouse model allowing unequivocal identification of PCDH19 
WT cells. Specifically, we utilised CRISPR-Cas9 genome engineering to insert a HA-FLAG 
epitope tag at the C-terminus of PCDH19 allowing detection of endogenous protein using 
commercially-available antibodies. We show for the first time PCDH19 spatial expression 
which was widely expressed in the developing brain, becoming restricted in the postnatal 
cortex.  
To investigate the phenotype resulting from disruption of PCDH19-dependent cell adhesion 
codes, we generated female mice with both Pcdh19HA-FLAG and Pcdh19 null alleles. 
Simultaneous staining with HA antibodies and X-gal revealed striking segregation of 
PCDH19-positive and PCDH19-null cortical neuroprogenitors. Abnormal cell sorting 
observed in heterozygous mice demonstrates that mosaic expression of PCDH19 generates 
distinct cell populations with incompatible adhesion codes. Furthermore, we show that the 
cell sorting phenotype could be removed by deleting the remaining PCDH19 WT allele in 
heterozygous female embryos. This confirms that the complete absence of PCDH19 rescues 
abnormal cell sorting and provides a clear cellular phenotype that is associated with 
PCDH19-GCE.  




Finally, analysis of MRI scans from a cohort of PCDH19-GCE patients revealed variable 
cortical folding abnormalities in four patients with commonly occurring PCDH19-GCE 
mutations.  
Overall Chapter 3 describes how the mosaic expression of Pcdh19 leads to the generation of 
differential adhesion codes in neural progenitor cells and appears to be the underlying 
cellular mechanism responsible for the unique X-linked inheritance pattern of PCDH19-
GCE.  
 









































Submitted Manuscript:  Confidential 
Title:  Abnormal cell sorting is associated with the unique X-linked inheritance 
of PCDH19 Epilepsy 
Authors:  Daniel T. Pederick1, 2, Kay L. Richards3, Sandra G. Piltz1, 2, Simone A. Mandelstam4, 5, 6, 
Russell C. Dale7, Ingrid E. Scheffer3, 8, Jozef Gecz1, 2, 9, 10, Steven Petrou3, James N. Hughes1, 2 and 
Paul Q. Thomas1, 2, 10* 
Affiliations: 
1School of Biological Sciences, The University of Adelaide, Adelaide, South Australia 5005, 
Australia 
2Robinson Research Institute, The University of Adelaide, Adelaide, South Australia 5005, Australia 
3Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, 
Victoria 3010, Australia 
4Department of Paediatrics, The University of Melbourne, Melbourne, Victoria 3010, Australia 
5Department of Radiology, The University of Melbourne, Melbourne, Victoria 3010, Australia 
6Department of Medical Imaging, Royal Children's Hospital, Florey Neurosciences Institute, 
Parkville, Victoria 3052, Australia 
7Institute for Neuroscience and Muscle Research, University of Sydney8University of Melbourne, 
Austin Health and Royal Children’s Hospital, Victoria, 3084, Australia 
9School of Medicine, The University of Adelaide, Adelaide, South Australia 5005, Australia   
10 South Australian Health and Medical Research Institute, Adelaide, South Australia 5000, Australia 










X-linked diseases typically exhibit more severe phenotypes in males than females. In contrast, 
Protocadherin 19 (PCDH19) mutations cause epilepsy in heterozygous females but spare 
hemizygous males. The cellular mechanism responsible for this unique pattern of X-linked 
inheritance is unknown. We show that PCDH19 contributes to highly specific combinatorial 
adhesion codes such that mosaic expression of Pcdh19 in heterozygous female mice leads to striking 
sorting between WT PCDH19- and null PCDH19-expressing cells in the developing cortex, 
correlating with altered network activity. In addition, we identify variable cortical malformations in 
PCDH19 epilepsy patients.  Our results highlight the role of PCDH19 in determining specific 
adhesion codes during cortical development and how disruption of these codes is associated with the 
unique X-linked inheritance of PCDH19 epilepsy.    
 
One Sentence Summary:  A single difference in PCDH expression disrupts complex adhesion codes 















Main Text:  
Protocadherins (PCDHs) are the largest family of adhesion molecules and regulate axon 
guidance/sorting, neurite self-avoidance and synaptogenesis (1–3). Mutations in PCDH 
family members have been associated with a variety of neurological disorders including 
epilepsy, autism and schizophrenia (4–7). Notably, mutations in Protocadherin 19 
(PCDH19) cause PCDH19 Girls Clustering Epilepsy (PCDH19-GCE) which is reported to 
be the second most common cause of monogenic epilepsy (8, 9). PCDH19-GCE is an X-
linked disorder with a unique pattern of inheritance whereby heterozygous females are 
affected while hemizygous males are spared (8, 10). It has been proposed that the coexistence 
of WT and mutant PCDH19 neurons that arise through random X-inactivation underpins the 
unique inheritance (8, 11). This hypothesis is supported by the existence of affected males 
who are mosaic carriers of somatic PCDH19 mutations (11). However, it is currently unclear 
what processes are regulated by PCDH19 in the brain and how these are disrupted by mosaic 
expression but not by the complete absence of functional protein.  
 
PCDH19 has been shown to function as a homotypic cell adhesion molecule in vitro (12) 
and recently published data indicate that PCDH19 has a virtually identical structure to 
members of the closely-related clustered PCDH family (13). Interestingly, clustered PCDHs 
have been shown to form combinatorial adhesion codes that are likely to play a role in 
vertebrate neuronal self-avoidance (14–16). Given the overlapping expression of non-
clustered (NC) PCDHs in vivo (17, 18), we hypothesized that PCDH19, in combination with 
other NC PCDH family members, could contribute to complex adhesion codes and that 
perturbation of these codes underpins the unique X-linked inheritance pattern of PCDH19-
GCE.  





To investigate the adhesion activity of PCDH19 in combination with other NC PCDHs we 
performed mixing experiments using K562 cells which ordinarily do not aggregate during 
culture due to a lack of endogenous PCDHs and classical cadherins (16, 19). PCDH17 and 
PCDH10 were selected for these experiments due to their ability to interact in cis with 
PCDH19 when co-expressed in the same cell in a co-immunoprecipitation assay (Fig. 1A) 
and overlapping expression with Pcdh19 in the embryonic mammalian brain (17). K562 
cells transfected with different fluorescently-labelled PCDH combinations were mixed in a 
1:1 ratio and quantitatively assessed for the presence/absence of sorting between the two 
populations (Fig. 1B). When both cell populations expressed the same combination of 
PCDHs random mixing was observed (Fig. 1C). In contrast, populations expressing different 
PCDH combinations exhibited significant cell sorting indicating that cells with matching 
PCDH profiles preferentially adhere (Fig. 1C). Notably, significant sorting occurred 
between populations that differed by a single PCDH.  We next assessed the impact of 
PCDH19-GCE missense mutations on combinatorial PCDH adhesion. We first individually 
expressed PCDH19 containing one of three commonly occurring missense mutations in 
K562 cells and found that each lacked adhesive function (Fig. S1), consistent with previously 
reported data for other missense mutations (13). When PCDH10 was co-expressed with 
either WT PCDH19 or mutant PCDH19.N340S, significant sorting occurred between the 
two populations (Fig. 1C). Taken together, these data suggest that PCDH19 forms 
heterotypic cis interactions with NC PCDHs and contributes to combinatorial adhesion codes 
that are sensitive to single PCDH differences. 
 
Next, we sought to investigate how perturbation of these adhesion codes would manifest in 
the developing mammalian brain where complex arrays of adhesion molecules direct 
morphogenesis.  For these experiments we used mice carrying a null allele (Pcdh19β-Geo) 





(20) to generate female heterozygous mice with mosaic expression of Pcdh19. Given the 
seizures and elevated neural activity of PCDH19-GCE affected females (21, 22), we initially 
performed electrocorticogram (ECoG) analysis on young adult mice to investigate if a 
phenotype exists in heterozygous mice that does not manifest in homozygote animals. ECoG 
traces from Pcdh19+/β-Geo (+/β-Geo) postnatal day 42 (P42) mice showed a consistent 
increase in amplitude compared to Pcdh19+/+ (+/+) and Pcdh19β-Geo/β-Geo (β-Geo/β-Geo) 
animals, which were themselves indistinguishable (Fig. 2A). Strikingly, ECoG signatures 
for +/β-Geo mice showed a significant increase in mean number of spike-wave discharge 
(SWD) events per hour and event duration compared with +/+ mice (Fig. 2B, C and S2). In 
contrast, the mean number of SWDs per hour and the mean duration of a SWD event for β-
Geo/β-Geo animals was not significantly different to +/+ mice (Fig. 2B, C and S2).  This 
indicates that mosaic expression of Pcdh19 in mice results in altered brain network activity. 
In contrast, this phenotype is not present in mice completely lacking PCDH19, consistent 
with the unique X-linked inheritance of PCDH19-GCE in humans. 
 
To determine the impact of mosaic PCDH19 expression at the cellular level in vivo we 
required reporter alleles for Pcdh19-expressing WT and null cells. To label Pcdh19-
expressing null cells, we used the Pcdh19β-Geo β-galactosidase knock-in reporter allele, 
which we had previously validated using X-Gal staining (20). To enable unequivocal 
identification of WT PCDH19-expressing cells, we employed CRISPR-Cas9 genome editing 
to insert an HA-FLAG epitope sequence at the C-terminus of the PCDH19 ORF (Fig. S3A). 
Successful insertion was validated via PCR, sequencing, western blot and HA 
immunohistochemistry (Fig. S3B, C and D, respectively). Consistent with previously 
published mRNA in situ hybridization data (8, 20, 23), we detected PCDH19 expression in 





many brain regions, including prominent expression in the developing cortex that became 
more restricted in the postnatal brain (Fig. S3D, E and S4).   
 
Simultaneous labelling of PCDH19 positive (HA) and negative (X-gal) cells in Pcdh19HA-
FLAG/β-Geo (HA-FLAG/β-Geo) brains enabled us to investigate the phenotype resulting from 
disruption of PCDH19-dependent cell adhesion codes.  HA immunostaining of HA-FLAG/β-
Geo brains revealed a striking alternating pattern of PCDH19-positive and PCDH19-
negative cells that extended from the ventricular zone to the cortical plate. (Fig. 2D, left). X-
gal staining of HA-FLAG/β-Geo brains revealed a complementary and non-overlapping 
pattern to HA immunostaining (Fig. 2D, left), suggesting this pattern is due to segregation 
of PCDH19-positive and PCDH19-null cells  To confirm that this pattern did not arise due 
to random X-inactivation and subsequent clonal expansion, we examined HA-staining in 
“wild type” Pcdh19HA-FLAG/+ (HA-FLAG/+) control embryos (Fig. 2D, right). This allowed 
us to identify the pattern of PCDH19-positive HA labelled cells in the presence of PCDH19-
positive unlabelled cells. Within the cortex, X-inactivation manifested as small interspersed 
patches of HA-positive and HA-negative staining along the ventricle and overlying neural 
progenitors in the ventricular zone, with only subtle variations in HA staining within the 
cortical plate (Fig. 2D, right). The significantly increased percentage of HA-negative regions 
in HA-FLAG/β-Geo embryos compared with HA-FLAG/+ controls confirms that PCDH19-
positive and PCDH19-null cells coalesced into distinct groups (Fig. 2E). We also noted 
significantly increased variation of HA-immunostaining across different HA-FLAG/β-Geo 
animals, suggesting differences in abnormal cell sorting phenotypes are due to unique 
patterns of X-inactivation in each embryo (Fig. 2F, S5 and S6).  Consistent with an active 
role in cell sorting, PCDH19 was present at interfaces between PCDH19 expressing radial 
glial cells but not between PCDH19-positive and negative cells, supporting its role as a 





homotypic cell-cell adhesion molecule in vivo (Fig. S7). Cell body redistribution was 
independently confirmed by staining for nuclear-localised SOX3 in Pcdh19+/β-Geo; Sox3+/- 
trans-heterozygous mice (Fig. S8). Taken together, these data suggest that mosaic expression 
of Pcdh19 in neuroprogenitors generates distinct cell populations with incompatible 
adhesion codes that abnormally segregate during cortical development.    
 
The absence of pathology in hemizygous males and the normal brain activity of mice 
completely lacking functional PCDH19 (Fig. 2A, B and C) suggests that the removal of 
differential adhesion codes dictated by mosaic PCDH19 expression will restore normal cell 
sorting during cortical development. To test this hypothesis we developed a method to assess 
in vivo cell sorting by visualising Pcdh19 allele-specific expression in functionally null 
PCDH19 female mice. Using CRISPR-Cas9 genome editing, we deleted the Pcdh19HA-FLAG 
allele in HA-FLAG/β-Geo zygotes to create DEL/β-Geo null embryos (Fig. 2F). Deletion of 
exon 1 and lack of functional PCDH19 was validated by sequencing and HA 
immunostaining (Fig. 2G and data not shown). X-gal staining of DEL/β-Geo embryos at 14 
days post embryo transfer demonstrated that the two populations of null cells readily 
intermix, thereby rescuing the abnormal cell sorting phenotype observed in HA-FLAG/β-
Geo embryos (Fig. 2G). Quantification of X-gal staining variation confirmed that the 
abnormal cell sorting was rescued in DEL/β-Geo cortices (Fig. 2I and S4). This provides 
further evidence that the differential adhesion codes of PCDH19-positive and PCDH19-
negative cells leads to abnormal cell sorting. Importantly, the lack of abnormal cell sorting 
in DEL/β-Geo null embryos provides a clear cellular phenotype that correlates with and 
likely explains the unique X-linked inheritance of PCDH19-GCE.  
 





Given that cortical neuroprogenitor cells predominantly undergo radial as opposed to lateral 
movement (24), the presence of large blocks of cells in HA-FLAG/β-Geo embryos at 14.5dpc 
suggests that abnormal cell sorting must occur at an earlier stage in development. We were 
also interested to determine whether abnormal cell sorting persists in post-mitotic neurons.  
Initially, we established that PCDH19 expression in the developing brain commences at 9.5 
dpc (Fig. S9). Comparison of HA-FLAG/+ and HA-FLAG/β-Geo embryos at 9.5 dpc 
revealed a similar pattern of highly interspersed PCDH19-positive and -negative cells (Fig. 
3A) indicating that segregation had not yet occurred. In contrast, at 10.5 dpc abnormal cell 
sorting was evident in HA-FLAG/β-Geo embryos but not in HA-FLAG/+ controls (Fig. 3A). 
In addition, abnormal cell sorting was observed in postnatal neurons that express PCDH19 
(Fig. 3B). The rapid onset and persistence of abnormal cell sorting demonstrates that cortical 
progenitors are acutely sensitive to disruptions in specific adhesion codes and that these 
embryonic cellular rearrangements are maintained in postmitotic neurons.  
Although central nervous system (CNS) abnormalities have not previously been described 
in +/β-Geo mice (20) we hypothesized that abnormal cell sorting caused by mosaic 
expression of PCDH19 during human cortical development could result in morphological 
defects due to the prolonged expansion of neuroprogenitors and extensive sulcation relative 
to mice (25). Using data from the Allen Brain Atlas we confirmed PCDH19 is highly 
expressed in human embryonic CNS including the cortex during the key neurogenic period 
of 8-16 weeks post conception (26, 27) (Fig. S10A). PCDH19 expression is reduced 
postnatally, but is still detectable, with the brain remaining the predominant site of 
expression in the adult (Fig. S10B). We then reviewed MRI images from a cohort of 
PCDH19-GCE girls. We identified abnormal cortical sulcation in four patients with common 
causative mutations in PCDH19 (p.N340S, p.S671X and p.Y366LfsX10; Fig.4, S11 and 
Table S2) (21). The patients presented with variably positioned cortical defects that included 





bottom of the sulcus dysplasias, abnormal cortical folding, cortical thickening and blurring 
of the grey/white junction. These data suggest that subtle CNS abnormalities are a feature of 
PCDH19-GCE, which is supported by previous observations of dysplastic neurons (10). 
While it is not known how abnormal cell sorting could generate these defects, their 
variability is consistent with the random nature of X-inactivation and phenotypes observed 
in PCDH19-GCE patients. 
 
In summary, the generation of differential adhesion codes in neural progenitor cells caused 
by mosaic expression of Pcdh19 appears to be the underlying cellular mechanism 
responsible for the unique X-linked inheritance pattern of PCDH19-GCE. Furthermore, our 
data suggests that uniform removal of PCDH19, as seen in hemizygous males, does not lead 
to the formation of incompatible adhesion codes allowing for normal positioning of 
neuroprogenitor cells and neural activity (Fig. S12). The abnormal rearrangement of 
neuroprogenitor cells in the incipient cortex of heterozygous brains indicates that at least 
some of their neuronal progeny will be aberrantly positioned, regardless of whether they 
maintain expression of Pcdh19 postnatally. This rearrangement has the potential to perturb 
functional boundaries within the cortex and alter connectivity between cortical and 
subcortical regions.  
 
More broadly, our data suggests that neurodevelopmental disorders associated with mutation 
of other NC PCDH family members (4–7) may be caused by disruption of adhesion codes. 
Since all other NC PCDHs are autosomal, mosaic disruption of adhesion codes would have 
to occur through a process other than X-inactivation. There is strong evidence that NC 
PCDHs are subject to random monoallelic expression (RMAE) (28). Individuals with a 





heterozygous germ line mutation in a given autosomal NC PCDH would have a proportion 
of their cells expressing either the functional or non-functional allele, resulting in disrupted 
adhesion codes. The proportion of RMAE affected cells would likely impact the penetrance 
or expressivity of any resultant phenotype.   
Although both clustered and NC PCDHs can function in combinatorial adhesion complexes, 
our data indicates that the interaction of matching adhesion codes for each of these closely-
related protein families in vivo can lead to different outcomes. Matching codes of clustered 
PCDHs are thought to result in repulsion which has been implicated in neuronal self 
avoidance. In contrast, our data indicate that cells expressing matching NC PCDH codes 
selectively associate in vivo. Given the complex and overlapping expression pattern of NC 
PCDHs throughout development it seems likely that this property may direct spatial 
positioning of neuroprogenitors and could conceivably be utilized during morphogenesis of 
other organs. 
 
The ability of cells with different identities to self-associate and form discrete populations 
was first identified in the early 1900s by mixing sponge cells from different colored species 
(29–31). We now appreciate the critical role of adhesion molecules in regulating cell identity 
and directing tissue morphogenesis in many developmental contexts including in the brain 
(32–35). Our findings advance this field by providing evidence that perturbation of cellular 
adhesion codes underlies the unique X-linked inheritance pattern of PCDH19-GCE and 
suggests that just a single difference in PCDH expression is enough to disrupt the complex 
adhesion codes present within the developing mammalian cortex.  
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Fig. 1. δ2 non-clustered PCDHs form combinatorial codes which dictate adhesion specificity. 
(A) Co-immunoprecipitation of K562 cell lysates expressing PCDH combinations indicated by the 
+ symbol. Lysates were pulled-down with FLAG Ab and subsequent blotting was performed with 
MYC Ab (N=3 experiments). Cis interaction of FLAG-PCDH19 with MYC-PCDH19, MYC-
PCDH17 and MYC-PCDH10 was detected. Cells transfected with PCDHγC3-FLAG and Ncad-
MYC served as a negative control for cis-interaction as previously reported (14). (B) Schematic 
diagram describing mixing assays performed to assess adhesion specificity. Fluorescently-labelled 
K562 cells expressing different NC PCDH combinations were mixed in a 1:1 ratio, allowed to 
aggregate and quantitatively assessed for the degree of mixing/sorting between the two populations. 
(C) Quantification of the degree of mixing using Pearson’s correlation coefficient. Expression 
constructs are indicated by 19 (PCDH19), 17 (PCDH17), 10 (PCDH10) and 19.N340S (PCDH19 
N340S missense mutation) (***P < 0.001, ****P <  0.0001,  ns=not significant, one-way analysis 
of variance (ANOVA) with Tukey’s multiple comparison test against 19/10 +19/10 unless otherwise 
indicated). Representative images of quantified K562 mixing assays. Cell sorting is observed when 
populations differ by just one NC PCDH (panels (2), (3), (4), (5)), in contrast to mixing which occurs 
in populations express the same NC PCDHs (panel (1)). See Table S1 for additional information 






















Fig. 2. Mosaic expression of Pcdh19 causes altered network brain activity and abnormal cell 
sorting between PCDH19 positive and PCDH19 negative cells in the developing cortex. (A) 
Representative 5 minute traces from ECoG recordings of +/+, +/β-Geo and β-Geo/β-Geo P42 mice. 
(B) Quantification of SWD/hr of +/+, +/β-Geo and β-Geo/β-Geo P42 mice (****P < 0.0001, **P < 
0.01, ns=not significant, student’s two-tailed, unpaired t test p values). (C) Quantification of mean 
SWD duration of +/+, +/β-Geo and β-Geo/β-Geo P42 mice (****P < 0.0001, *P < 0.05, ns=not 
significant, two-way ANOVA with Tukey’s multiple comparisons test). (D) Representative HA and 
X-gal immunostaining of 14.5 dpc HA-FLAG/+ and HA-FLAG/β-Geo brains. Large blocks of HA-
positive and HA-negative cells are present in the ventricular zone (VZ) of the cortex which extended 
into the intermediate zone (IZ) and cortical plate (CP) of HA-FLAG/β-Geo embryos (left). In contrast, 
small patches of HA-negative cells were present along the ventricle of HA-FLAG/+ (indicated by 
arrowheads) which did not extend into the intermediate zone (IZ) and cortical plate (CP) (right). (E) 
Quantification of HA-negative regions in the cortex of 14.5 dpc HA-FLAG/β-Geo and HA-FLAG/+ 
and brains (**P < 0.01, unpaired t test). (F) Quantification HA-immunostaining intensity throughout 
the cortex revealed a higher degree of variability in HA-FLAG/β-Geo compared with HA-FLAG/+ 
(*P < 0.05, unpaired t test). (G) Schematic describing CRISPR-Cas9-induced conversion of HA-
FLAG/β-Geo embryos to DEL/β-Geo. Two gRNAs targeting exon1 flanking sequences (red arrows) 
were injected into HA-FLAG/β-Geo zygotes in combination with CAS9 protein. Zygotes were 
transferred into pseudopregnant female mice and harvested 14 days post transfer. (H) HA and X-gal 
immunostaining of HA-FLAG/β-Geo and DEL/β-Geo 14 day post transfer embryonic brains). 
Normal redistribution of PCDH19 null cells was observed in the cortex of DEL/β-Geo embryos 
indicating that preventing the disruption of PCDH19-dependent adhesion codes abolishes abnormal 
cell sorting. (I) Quantification of X-gal staining intensity throughout the ventricle revealed a higher 
degree of variability in HA-FLAG/β-Geo brains compared to HA-FLAG/+ brains (**P < 0.01, 










































Fig. 3. Early cortical progenitor cells are acutely sensitive to mosaic expression of Pcdh19. (A) 
Representative images of HA and SOX3 (neuroprogenitor marker) co-immunostaining of 9.5dpc and 
10.5dpc HA-FLAG/+ and HA-FLAG/β-Geo heads (N=3 of each genotype). Abnormal cell sorting is 
not apparent at 9.5dpc (right) but one day later the segregation of PCDH19-postive and PCDH19-
null cells has occurred (left). (B) HA immunostaining of P7 HA-FLAG/+ and HA-FLAG/β-Geo 















































Fig. 4. Mosaic expression of PCDH19 results in variable cortical folding abnormalities in 
PCDH19-GCE patients. Patient A: A focal area of cortical thickening in the left mid frontal lobe 
(open arrow) and mild cortical thickening and blurring of the grey/white interface in the left posterior 
temporal lobe was observed in axial T1 weighted MRI images (closed arrow).  Patient B: Axial T1 
weighted MRI images show an unusual stellate configuration to the right central sulcus with loss of 
cortical clarity (open arrow) and a focal retraction/puckered appearance of right lateral frontal cortex 
with complex sulcation and deep cortical thickening suggesting a likely bottom of the sulcus 
dysplasia (closed arrow). A focal area of suspected cortical dysplasia was identified in the left mid 
frontal region in addition to cortical thickening (arrowhead). Patient C: Axial and sagittal images 
show an unusual complex sulcal arrangement present in the right frontal lobe with 2 parallel sulci 
forming an ovoid ring configuration (closed arrows). Patient D: Contiguous coronal T1 images reveal 
cortical thickening with blurring of the grey/white junction which is highly suggestive of a left 
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Materials and methods: 






Open reading frames (ORF) were purchased from either Vector Builder (PCDH10 and 
PCDH17) or Promega (PCDH19). Tagged ORFs were generated by PCR and point 
mutations were created using overlap extension PCR. All ORFs were cloned into GFP or 
Mcherry containing expression plasmids using restriction enzymes. Primer sequences used 
for PCR amplifications will be provided upon request.  
 
Co-immunoprecipitation and western blotting 
K562 cells (human leukemia cell line, ATCC CCL243) were transfected with 5µg of each 
plasmid using the Neon Transfection System (Invitrogen) and harvested 48 hours later. 
Transfected cells were homogenized in IP lysis buffer (25mM Tris-HCl (pH7.4), 150 mM 
NaCl, 1 mM EDTA, 1% NP-40, and 5% glycerol) in addition to cOmplete mini EDTA-free 
Protease Inhibitor Cocktail (Roche) and the PhosSTOP Phosphatase Inhibitor Cocktail 
(Roche). Cells were incubated in lysis buffer for 30 minutes at 4˚C, followed by brief 
sonication and another 30 minutes at 4˚C. The supernatant was collected by centrifugation 
at 13,200 rpm for 30 minutes at 4˚C. 1uL of mouse anti-FLAG (Sigma, F3165), was added 
to each supernatant and incubated overnight at 4˚C. 30µL of Dynabeads™ Protein G 
(Invitrogen) was added to each sample and incubated for 2 hours at 4˚C. Beads were washed 
3x in IPP150 wash buffer (150mM NaCl, 10mM Tris/HCl, 0.1% Igepal (Sigma) and 5% 
glycerol) and resuspended in 2X SDS load buffer.  Lysates were separated on Invitrogen 
Bolt™ precast 4-12% polyacrylamide gels and transferred to PVDF membrane before being 
blotted. Antibodies and their corresponding dilutions were: mouse anti-FLAG 1:5000 
(Sigma, F3165) and rabbit anti MYC (Cell Signalling Technology #2272S)   Membranes 
were blocked in 5% BSA + 5% skim milk in tris-buffered saline + 0.1% Tween20 (TBST) 





and antibodies were incubated with the membrane in 5% BSA in TBST at 4°C overnight. 
Membranes were developed using Bio-Rad Clarity Western ECL substrate and imaged using 
a Bio-Rad ChemiDoc. 
 
K562 Aggregation Assay 
2x106 K562 (human leukaemia cell line, ATCC CCL243) cells were nucleofected with 10µg 
of plasmid DNA using the Neon Transfection System (Invitrogen) and incubated for 24 
hours. Cells were harvested, treated with DNase (1mg/mL) and passed through a 40µm cell 
strainer (Falcon) to obtain a single cell suspension. 2x105 cells were added to each well of a 
12 well tray and allowed to aggregate for 2-4 hours on a nutator at 37˚C/5% CO2. Aggregated 
cells were imaged using a Nikon Eclipse Ti microscope. To quantify aggregate size images 
were exported to ImageJ where they were subjected to an equal threshold transformation and 
aggregate size was assessed using the “analyse particle” function. Raw data was transferred 
to GraphPad Prism 7 where a Kruskal-Wallis test was performed.  
 
Cytospin immunofluorescence 
K562 cell aggregates were fixed in 2% PFA for 2 hours at RT, washed in PBS and 
resuspended in 30% sucrose. Aggregate suspensions were then adhered to superfrost slides 
(ThermoFisher) using a Shandon Cytospin 3 (1000rpm, 10 minutes). Immunofluorescence 
was performed by blocking with 10% foetal calf serum for 1 hour and then incubating with 
mouse anti-FLAG (Sigma, F3165) 1/1000 overnight at 4˚C and then secondary antibody for 
2 hours at room temperature (donkey anti-mouse 488 (Jackson ImmunoResearch)). Images 
were acquired on a Leica SP5 Confocal microscope.  
 
K562 Mixing Assay 





2x106 K562 cells were nucleofected with 5µg of each plasmid DNA (10µg total for co-
nucleofections) and incubated for 24 hours. Cells were harvested, treated with DNase 
(1mg/mL) and passed through a 40µm cell strainer (Falcon) to obtain a single cell 
suspension. 1x105 cells from each sample were pooled and added to each well of a 12 well 
tray and allowed to aggregate for 3 hours on a nutator at 37˚C/5% CO2. Aggregated cells 
were imaged using a Nikon Eclipse Ti microscope. Each condition was performed in 
biological triplicate with four technical repeats. Pearson’s correlation coefficient was 
calculated using NIS Elements Advanced Research Software (Nikon). Raw data was 
transferred to GraphPad Prism 7 where a one way ANOVA test was performed. 
 
Electrocorticogram (ECoG) recordings 
ECoG recordings were obtained from 6-week-old female mice for wild type (WT), 
heterozygote (Het) and knock-out (KO) animals in DBA/2J background (>N9). Surgery for 
ECoG electrode placement was performed as described previously (36). In brief, mice were 
anesthetized with 2-4% isoflurane and 2 epidural silver “ball” electrodes implanted on each 
hemisphere above the somatosensory cortices using the following  co-ordinates with respect 
to bregma: (ML + 3 mm and AP -0.7 mm). A ground electrode was positioned 2.5 mm rostral 
and 1 mm lateral from bregma. Mice were allowed to recover for at least 72 hours post-
surgery. Continuous ECoGs were then recorded in freely moving animals for 3-hour epochs 
during daylight hours following a standard 30-minute habituation period; a minimum of 9 
hours recording was obtained for data analysis. Signals were band pass filtered at 0.1 to 200 
Hz and sampled at 1 kHz using Powerlab 16/30 (AD Instruments Pty. Ltd., Sydney, NSW, 
Australia). In a subset of mice simultaneous video/ECoG recordings were also obtained to 
correlate behaviour. The spike wave discharge (SWD) signature of  +/+, +/β-Geo and β-
Geo/ β-Geo mice on a DBA/2J background was 5-8Hz as previously reported for this genetic 
background (37, 38). 5 Quantification of spike wave discharges (SWD) was done for each 





genotype based on rhythmic biphasic spikes with voltage at least two-fold higher than mean 
background. Measurements for SWD duration were made for a total of 350 events, defined 
as time from the first spike peak to final peak with a minimum of one-second duration. 
 
Generation and Genotyping of Pcdh19HA-FLAG Mice 
CRISPR gRNA was designed to target near the stop codon of PCDH19 (5’-
TATCGTTCTCTAAAGCCATC-3’) using CRISPR Design tool (crispr.mit.edu) and 
generated in house by cloning 20 nt oligos into pX330-U6-Chimeric_BB-CBh-hSpCas9, 
which was a gift from Feng Zhang (Addgene plasmid # 42230) according to the protocol 
described in (39). The ssDNA HA-FLAG oligo was designed to insert HA-FLAG 5’ of the 




AGTGAAGATGTAGCAG-3’) (Integrated DNA Technologies (IDT)). Cas9 mRNA was 
generated by IVT (mMessage) from pCMV/T7-hCas9 (Toolgen) digested with XhoI. The 
gRNA (50ng/µL), Cas9 mRNA (100ng/µL) and ssDNA HA-FLAG donor oligo (100ng/µL) 
(IDT) were injected into C57BL/6N zygotes, transferred to pseudopregnant recipients and 
allowed to develop to term. Founder pups were screened for HA-FLAG insertions by PCR 
across targeted region (F 5’-TAGCGTGAAGCGTCTGAAGG-3’, R 5’-
CAGGCAGTAGGGGTGTTCAG-3’) and run on an agarose gel. A larger product of 281bp 
represented the HA-FLAG allele, while a smaller 230bp product represented the wild type 
allele.  Positive samples were Sanger sequenced to verify the correct insertion of the HA-
FLAG sequence. Routine genotyping was performed by agarose gel electrophoresis in which 
PCR products generated with the above primers were separated. The gender of embryos was 





identified by PCR amplification of SRY  (F 5’-CAGTTTCATGACCACCACCA-3’ and R 
5’-CATGAGACTGCCAACCACAG-3’) and the gender of postnatal mice was assessed by 
analysis of external genitalia. All animal work was conducted following approval by The 
University of Adelaide Animal Ethics Committee (approval number S-2013-187, S-2014-
068, S-2014-199A) in accordance with the Australian code for the care and use of animals 
for scientific purposes.  
 
Protein Extraction and western blotting 
Hippocampi for protein extraction were minced in extraction buffer (50mM Tris, 150mM 
NaCl, 1% NP40 (Roche) and 1% Triton X-100 (Sigma)) and incubated at 4˚C for 30 minutes. 
Lysates were separated on Invitrogen Bolt™ precast 4-12% polyacrylamide gels and 
transferred to PVDF membrane before being blotted. Antibodies and their corresponding 
dilutions were: mouse anti-PCDH19 1:200 (Abcam, ab57510), mouse anti-FLAG 1:5000 
(Sigma, F3165), mouse anti-HA 1:1000 (Cell Signalling Technology #2367) and rabbit anti-
β-ACTIN 1:1000 (Cell Signalling Technology, #4697). Membranes were blocked in 5% 
BSA + 5% skim milk in tris-buffered saline + 0.1% Tween20 (TBST) and antibodies were 
incubated with the membrane in 5% BSA in TBST at 4°C overnight. Membranes were 




8.5dpc, 9.5 dpc and 10.dpc whole embryos were dissected and fixed for 2-6 hours in 4% 
paraformaldehyde (PFA) at 4˚C. To collect 13.5dpc, 14.5dpc and 15.5dpc embryonic brains 
pregnant dams were cardiacally perfused with 4% PFA. Embryonic brains were dissected 
and post fixed in 4% PFA at 4˚C for 4-6 hours. To collect P7 brains mice were cardiacally 





perfused with 4% PFA, brains dissected and post fixed in 4% PFA at 4˚C for 4-6 hours. 
Embryos and brains were then cryoprotected in 30% sucrose and frozen in OCT embedding 
medium. 16µm sections were cut using a Leica CM1900 cryostat. Sections were blocked 
with 0.3% TritonX-100 and 10% horse serum in PBS for 1 hour at room temperature. 
Sections were then incubated overnight with rabbit anti-HA 1:300 (Cell Signalling 
Technology, #3724), goat anti-SOX3 1:300 (R&D Systems, AF2569), rat anti-CTIP2 1:400 
(Abcam, ab18465) and rabbit anti-CUX1 1:400 (Santa Cruz, sc-13024) at 4˚C and then 
secondary antibody for 2 hours at room temperature (donkey anti-rabbit TxRed (Life 
Tehcnologies), donkey anti-goat 488 (Life Technologies), donkey anti-guinea pig 488 
(Jackson ImmunoResearch) and goat anti-rat 488 (Jackson ImmunoResearch). Images were 
acquired on a Nikon Eclipse Ti microscope false coloured using Adobe Photoshop.  
 
X-Gal staining 
14.5dpc brains were collected as described above. Staining was performed as previously 
described (20). Images were acquired on a Nikon Eclipse Ti microscope and false coloured 
using Adobe Photoshop.  
 
X-gal and immunofluorescence co-staining 
X-gal staining was performed then followed by immunofluorescence staining as described 
above. Images were acquired on a Nikon Eclipse Ti microscope and false coloured using 





Quantification of HA negative areas 





Images from HA-FLAG/β-Geo transformed until HA-negative regions in HA-FLAG/β-Geo 
cortices became blank pixels. Equal thresholding was performed on HA-FLAG/+ images. 
Regions of interest were drawn around the cortex of all images and the percent of HA-
negative area (blank pixels) was assessed. Raw data was transferred to GraphPad Prism 7 
where a Student’s T-test was performed.     
 
Quantification of HA immunostaining intensity variability  
21 regions of interest (50µm x 50µm) were placed throughout the cortex and intensity 
measured using NIS Elements Advance Research Software (Nikon). Raw data was 
transferred to GraphPad Prism 7 where the coefficient of variation was calculated.  
   
 
Generation of DEL/β-Geo embryos from HA-FLAG/β-Geo zygotes 
CRISPR gRNAs were designed to target immediately after the Pcdh19 ATG and the 3’ end 
of exon 1 (5’-CGGGACGGTGATCGCTAACG-3’) and (5’- 
AGATCCGGACCTACAATTGC) respectively and generated as above. The gRNA 
(25ng/µL each) and CAS9 protein (50ng/µL) were combined and incubated for 10 minutes 
on ice before being injected into Pcdh19HA-FLAG/β-Geo zygotes which were then transferred to 
pseudopregnant recipients. 14 days post transfer embryonic brains were collected and fixed 
for 4-6 hours in 4% PFA at 4˚C.  
Embryos were screened for the presence of HA-FLAG alleles by PCR as described above to 
confirm Pcdh19HA-FLAG/β-Geo identity. Pcdh19HA-FLAG/β-Geo embryos were then screened for 
large deletions of exon1 by PCR ( F 5’-GCAATCTCAGCATTGGAGCC-3’) (R 5’- 
GGGGTTTTTAGACCGACCGA-3’). Large deletions of exon 1 were confirmed via Sanger 
sequencing.  Pcdh19HA-FLAG/β-Geo embryos positive for large deletions were then processed 





for HA and X-Gal staining as described above, along with Pcdh19HA-FLAG/β-Geo embryos to 
serve as controls. 
Quantification of X-gal staining intensity variability  
14 regions of interest (50µm x 50µm) were placed throughout the ventricular zone of the 
cortex and intensity measured using NIS Elements Advance Research Software (Nikon). 































































Fig. S1. PCDH19-GCE missense mutations lack adhesive function. (A) K562 cells transiently 
expressing PCDH19 form aggregates whereas cells K562 cells expressing PCDH19-GCE mutations 
do not. (B) Quantification of aggregate particle size confirms the lack of adhesive function in 
PCDH19-GCE missense mutations. (n=2 biological repeats with 10 technical replicates, **, p<0.01, 
****, p<0.0001). (B) FLAG immunohistochemistry of K562 cells, white arrows indicate enrichment 


































Fig. S2. +/β-geo mice display increased SWD frequency, duration and epileptiform events 
during sleep. (A) Representative trace showing multiple SWDs highlighting the increased frequency 
of SWDs in +/β-Geo mice. (B) Single representative SWDs highlighting the increased duration of 
SWDs in +/β-Geo mice.  




































Fig. S3. Generation of Pcdh19HA-FLAG mice using CRISPR-Cas9 editing reveals PCDH19 
expression in the developing and postnatal brain. (A) Pcdh19HA-FLAG targeting strategy showing 
the HA-FLAG epitope (green), gRNA (red), PAM site (orange) and endogenous STOP codon 
(underlined). (B) PCR amplification was used to identify the insertion of the HA-FLAG epitope tag. 
(C) Protein extracts from P14 hippocampus were immunoblotted with PCDH19, FLAG, HA and β-
ACTIN antibodies. (D) HA-immunostaining of 14.5 dpc Pcdh19+/Y and Pcdh19HA-FLAG/Y (n=3). (E) 
HA immunostaining of P7 Pcdh19HA-FLAG brains and co-staining with layer markers CTIP2 (layer 





















Fig. S4. PCDH19 has widespread expression throughout brain development. HA-
immunostaining of HA-FLAG/Y embryonic brains revealed PCDH19 expression in the cortex, 
























Fig. S5. Raw data used to quantify the variation seen between HA-FLAG/β-Geo animals. (A) 
Box and whisker plot demonstrating range of HA immunostaining intensity values for each 
independent animal. (B) Box and whisker plot demonstrating range of X-gal staining intensity values 





































Fig. S6. Abnormal cell sorting patterns in HA-FLAG/β-Geo brains is variable. (A) HA 
immunostaining of HA-FLAG/+ brains at 13.5, 14.5 and 15.5 dpc. (B) HA immunostaining of HA-
FLAG/β-Geo brains at 13.5, 14.5 and 15.5 dpc. (C) X-Gal staining of HA-FLAG/β-Geo brains from 
(B) merged with HA images.  
 

























Fig. S7. PCDH19 is not present at cell-cell interfaces between WT PCDH19 and null PCDH19 
radial glial cells. (A) HA and Phalloidin staining of the ventricular lining of 10.5 dpc cortex (N=3 
of each genotype). PCDH19 is present at all cell-cell boundaries in HA-FLAG/Y brains (left, 
arrowheads) and at boundaries between HA-positive and HA-negative cells in HA-FLAG/+ brains 
(middle, arrowheads). In contrast, PCDH19 is not present at boundaries between HA-positive and 
HA-negative cells providing further evidence of its homotypic nature in vivo (right, arrowheads). 
(B) Schematic representation of PCDH19 location (green lines) overlapping with Phalloidin positive 





































Fig. S8. Cell segregation in the developing cortex is due to the redistribution of cell bodies. (A) 
SOX3 immunostaining of Pcdh19+/+ : Sox3+/-  13.5 dpc cortex shows normal X-inactivation (N=3). 
(B) SOX3 staining of Pcdh19+/β-Geo :Sox3+/- in 13.5 dpc cortex shows abnormal cell sorting of SOX3 
+ve and SOX3 –ve neural progenitor cells (N=3). SOX3 null mice were generated by CRISPR-Cas9 
mediated deletion of the whole ORF (unpublished data). 
  








Fig. S9. PCDH19 is first expressed at 9.5dpc in the developing cortex. (A) At 8.5dpc PCDH19 
expression is present in the surface ectoderm but no in the SOX3 +ve neuroepithelial cells (N=3) (B) 




















Fig. S10. PCDH19 expression is enriched in the human cortex throughout embryonic 
development. (A) RNA-seq data from the Allen Brain Atlas highlighting the differential expression 
of PCDH19 in brain regions throughout development (26). (B) Data from RNA-Seq of human 
individual tissues and mixture of 16 tissues (Illumina Body Map) was retrieved from EMBL-EBI 
ArrayExpress database under accession number E-MTAB-513 
(http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-513/) on 09/01/2016 highlighting the 
differential expression of PCDH19 across different regions of the adult human. (White boxes 


































Fig. S11. Pedigrees of PCDH19-GCE patients which present with cortical folding 
abnormalities. (A) Acquired mutation through paternal inheritance (21). (B) Mutation was de novo 
(unpublished data). (C) Mutation was de novo (unpublished data). (D) Acquired mutation through 
















Fig. S12. Mosaic expression but not the complete loss of PCDH19 leads to incompatible 
adhesion codes. (A) Wild type cells in normal individuals have a complementary adhesion code 
(AC) which contains PCDH19, allowing interaction between cells. (B) Mosaic expression of 
PCDH19 leads to a mixture of cells that contain different adhesion codes. This causes wild type (AC) 
and null (AC-19) cells to have different adhesion codes and interact with cells that have a 
complementary adhesion code. (C) The complete loss of PCDH19 uniformly removes PCDH19 from 
all cells and therefore does not affect complementary adhesion codes.  
 
 































Table S1. Brief clinical description of PCDH19-GCE patients which have cortical folding 
abnormalities. FIAS, focal impaired awareness seizure; GTCS, generalised tonic-clonic seizure; 
FBTC, focal bilateral tonic-clonic seizure; T, tonic; FT, focal tonic; H, hemiclonic; Ab, absence; MJ, 
myoclonic jerks; At, atonic; m, months; y, years; F, female; M, male; GSW, generalised spike-wave; 
AED, anti-epileptic drug; PSW, polyspike-wave; w, weeks; SE, status epilepticus; DD, 
developmental delay; VEM, video EEG monitoring; CSE, convulsive status epilepticus; ID, 
intellectual disability; pat inh, paternally inherited; VNS, nagal nerve stimulator; LEV, levetiracetam; 
VPA, sodium valproate; LTG, lamotrigine; PB, phenobarbitone; PHT, phenytoin; CBZ, 
carbamazepine; CZP, clonazepam; CLB, clobazam; TPM, topiramate; KD, ketogenic diet; OCD, 
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Together the data presented from Chapters 2 and 3 indicate that loss of Pcdh19 does not 
overly affect mouse brain development but when expressed in a mosaic fashion causes 
abnormal cell sorting between Pcdh19 WT and Pcdh19 null cells. Furthermore, we show 
that abnormal cell sorting in the developing cortex correlates with altered network brain 
activity consistent with changes that can underlie seizures which is not observed in mice 
completely lacking Pcdh19. We also provide evidence supporting the combinatorial activity 
of NC PCDHs contributing to specific cell-cell interactions, which when disrupted leads to 
abnormal cell sorting. Overall we provide a long sought after cellular mechanism for the 
unique X-linked inheritance pattern of PCDH19-GCE. However, the examination of results 
from Chapters 2 and 3 together raise additional discussion points which are addressed below.  
 
In Chapter 2 we reported no gross morphological abnormalities in Pcdh19+/β-Geo and 
Pcdh19β-Geo/β-Geo brains and identified no spontaneous seizures in Pcdh19+/β-Geo mice. This 
may be due to the inherent difficulty of observing seizures in neonatal mice (the equivalent 
age where clusters of seizures present in PCDH19-GCE patients) or genetic differences 
between mice and humans. In fact, attempts to model epilepsy in mice do not always 
genetically match the corresponding human disorder. For example, heterozygous TSC1/2 
mutations in humans lead to Tuberous Sclerosis and seizures but an epilepsy phenotype is 
not observed in mice with heterozygous Tsc1/2 loss of function mutations (European 
Chromosome 16 Tuberous Sclerosis Consortium, 1993; Fryer et al., 1987; Kobayashi et al., 
2001; Onda et al., 1999). Similarly, heterozygous mutations in PRRT2 cause a range of 
epileptic and movement disorders that has recently been modelled using a Prrt2 null mouse 
(Michetti et al., 2017). Phenotypes representing epilepsy and movement disorders were only 
reported in Prrt2 homozygous mice and no pathogenic phenotype was observed in Prrt2 
heterozygous null mice. Despite the lack of seizures in Pcdh19+/β-Geo mice, it is important to 
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note that ECoG analysis identified an epileptic like phenotype. Therefore, the PCDH19-
GCE mouse model does follow the human inheritance pattern since Pcdh19+/β-Geo mice 
display epileptiform brain activity and Pcdh19β-Geo/β-Geo mice do not. We therefore conclude 
that heterozygous mice are an appropriate informative model to investigate the cellular 
mechanisms that underlie the disease. It appears likely that inherent differences in human 
and mouse brain development are the reason for the presentation of different phenotypes.  
We also show that the loss of Pcdh19 leads to a subtle increase in the migration potential of 
neurons in vitro. This was not seen in vivo as there were no ectopically positioned Pcdh19 
null neurons present in both the developing and adult brain. This was further supported by 
our findings in Chapter 3, where Pcdh19 WT and Pcdh19 null cells were both correctly 
positioned when simultaneously identified within the same brain. We therefore believe it is 
unlikely that the subtle migration defect seen in cultured Pcdh19 null neurons contributes to 
pathogenesis as we confirmed mice completely lacking Pcdh19 have normal brain activity. 
Instead the slightly increased migration potential may highlight another endogenous role of 
Pcdh19 that does not contribute to PCDH19-GCE. 
The abnormal cell sorting of neuroepithelial progenitors and radial glia raises the intriguing 
possibility that the entire mature cortex segregates according to their developmental 
expression of Pcdh19. If the entire cortex is subjected to rearrangement due to mosaic 
Pcdh19 expression, it is possible the epileptiform brain activity observed in adult Pcdh19+/β-
Geo is not only caused by defective connectivity between Pcdh19 WT and Pcdh19 null 
neurons but also contributed to by abnormal connections and spatial arrangement of other 
neurons. If the entire cortex was to undergo segregation it is likely this would result in 
abnormal organisation of functional cortical columns. Interestingly, cortical column 
organisation has been reported in gyrencephalic (folded) brains such as apes, monkeys and 
ferrets but there is little evidence supporting cortical column organisation in the 
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lissencephalic (smooth) brains of mice and rats (Chow et al., 1971; Shaw et al., 1975; Tiao 
and Blakemore, 1976). If abnormal cell sorting does occur throughout the entire cortex this 
neuronal architecture difference between humans and mice may contribute to the more 
severe phenotype seen in PCDH19-GCE patients. Furthermore, the identification of 
abnormal cortical sulcation in multiple PCDH19-GCE patients, suggests that aberrant cell 
sorting may generate different morphological phenotypes in gyrencephalic brains compared 
to lissencephalic brains. The cortical folding of human brains is largely caused by variable 
proliferation of basal radial glia, a cell type which is not present in the lissencephalic brain 
of mice. Proliferation of basal radial glia cause “wedges” of cell dense areas, which 
ultimately cause the brain to fold. It is possible that if segregation occurred within the basal 
radial glial cells in the developing human brain then abnormal folding may occur due to 
irregular formation of “wedges”.  These hypothesises could be investigated by using 
CRISPR-Cas9 technology to generate a Pcdh19+/- ferret (Kou et al., 2015), a gyrencephalic 
animal model, allowing any roles of PCDH19 specific to folded brains to be examined.  
 
X-Gal staining of Pcdh19+/β-Geo mice in Chapter 2 revealed “patchy” staining of Pcdh19 null 
cells which we attributed to normal X-inactivation. Due to the clonal and radial nature of 
excitatory neuron migration in the cortex we predicted X-inactivation would manifest as 
“columns” of either Pcdh19 WT or Pcdh19 null cells. This was in agreement with previous 
studies that utilised an X-linked β-galactosidase reporter where predominant columns of X-
Gal staining were present in the mouse cortex (Tan et al., 1995). At the time this research 
was undertaken the normal X-inactivation pattern of neurons in the cortex was not well 
understood. More recently, experiments have been performed to conduct a detailed analysis 
of X-inactivation in the mouse brain, by labelling both X-chromosomes with either GFP or 
tdTomato (Wu et al., 2014). It was reported that although there were regions in the cortex 
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predominantly originating from one X-chromosome there was always a degree of 
intermingling of both GFP and tdTomato positive cells. This agrees with the HA staining of 
control Pcdh19HA-FLAG/+ brains which showed that normal X-inactivation leads to grossly 
even distribution of PCDH19. Furthermore, these results highlight the significance of our 
finding that normal cell distribution is dramatically affected by mosaic expression of 
Pcdh19. The fact that we misinterpreted the “patchy” staining in heterozygous mice 
highlights the importance of controls. In our case it was not until we had generated a HA 
tagged mouse and stained HA/+ control mice that we were able to properly interpret the 
“patchy” staining in heterozygous mice as an abnormal cell sorting phenotype. 
 
Using a combination of in vitro and in vivo techniques we have shown that the abnormal cell 
sorting is due to disruption of PCDH19 dependent adhesion interfaces between 
neuroprogenitors cells at 10.5 dpc. During cortical development neuroprogenitors located in 
the ventricular zone predominantly undergo radial migration. We envisage two potential 
cellular consequences downstream of incompatible adhesion codes that could lead to 
segregation of neuroprogenitors; 1) the incompatibility between cells prevents lateral mixing 
(passive segregation); or 2) the incompatibility between cells promotes active sorting of 
neuroprogenitors. Our results suggest that the cells undergo active sorting as we observe 
small “blocks” only a few cells wide in 14.5-17.5 dpc brains. If lateral mixing was prevented, 
we would expect to see a minimum “block” size that would represent proliferation of a single 
“trapped “cell at 10.5 dpc (32 cells at 14.5 dpc with an assumed cell cycle of 12 hours). One 
caveat of our experiment is the two-dimensional analysis. It is possible, the small blocks we 
see at later stages are because we have “shaved” the edges of larger blocks. Analysis of the 
segregation pattern in three-dimensions would clarify this mechanism.  
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We show that PCDH19 and other members of the NC PCDH family can function in 
combinatorial activity which dictates cell-cell interaction specificities. This is similar to the 
cooperative activity of clustered PCDHs which have been proposed to form lattice like 
structures that act to differentiate between self and non-self neuronal processes (Rubinstein 
et al., 2015). Structural studies have further elucidated this mechanism showing that 
clustered PCDHs form tetramers that are maintained by trans homodimers through EC 
domains 1-4 and cis heterodimers through EC6 (Goodman et al., 2016; Nicoludis et al., 
2015; Rubinstein et al., 2015). The mechanism by which NC PCDHs act in combination is 
still to be determined and could potentially be similar to the lattice like structures formed by 
clustered PCDHs. This is supported by the recent structure analysis of zebrafish PCDH19 
highlighting its similarity to clustered PCDHs (Cooper et al., 2016). In addition, using co-
immunoprecipitation we showed that PCDH19 can interact with both PCDH17 and PCDH10 
when expressed in the same cell, supporting the ability of NC PCDHs to form cis 
heterodimers. In the future disease causing mutations positioned in domains important for 
trans (EC1-4) and cis (EC6) interactions could be assessed to determine how they impact 
the formation of trans and cis interactions. Cooper et al., 2016 showed that missense 
mutations within EC1-4 are positioned in domains crucial for homotypic trans interactions 
and we would predict that missense mutations within EC6 will affect cis heterodimeric 
interactions.  
Rubinstein et al., 2015 modelled the impact a single PCDH isoform mismatch has on the 
size of lattice structure between cells. They showed that a single mismatch between the 
PCDH profiles of two adjacent cells led to a dramatic decrease in lattice size, which they 
attributed to cause cell sorting in their in vitro experiments. We used the same modelling 
approach to determine if having one less PCDH between cells, as is the case in vivo using 
Pcdh19HA-FLAG/β-Geo mice, would result in the same dramatic decrease in lattice size. We show 
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that the lattice size between two cells where one cell has one less PCDH (N:N-1) modelling 
Pcdh19HA-FLAG/β-Geo mice, is dramatically reduced compared to a perfect match of PCDHs 
between two cells (N:N) (Figure 1-4). Furthermore, if both cells have the same PCDH 
removed (N-1:N-1), modelling Pcdh19β-Geo/β-Geo, mice the lattice size returns to almost 
normal levels, which agrees with the absence of a phenotype observed in Pcdh19β-Geo/β-Geo 
(Figure 1-4). In agreement with this we showed that we could remove NC PCDH 
incompatibility between PCDH19 WT and PCDH19 null cells by deletion of the remaining 




























Figure 1-4. The predicted size of adhesion complexes between PCDH19 WT and PCDH19 KO 
cells is dramatically reduced. Mathematical modelling predicts the size of adhesion complexes is 
dramatically reduced between PCDH19 WT and PCDH19 KO cells (green line) when compared to 
adhesion complexes between PCDH19 WT and PCDH19 WT (red line) or PCDH19 KO and 
PCDH19 KO cells (green line). Modelling was performed with 100 isomers of each PCDH molecule. 
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NC PCDHs could act in combination by determining the adhesive strength of cells. Cell 
sorting could then occur as cells with higher adhesion potential will cluster and the cells with 
lower adhesion potential will be excluded but still form their own cluster. We believe this 
mechanism is unlikely for multiple reasons; 1) cells in the developing cortex express many 
adhesion molecules, therefore it is unlikely the removal of just PCDH19 (a relatively weak 
adhesion molecule) would lead to a dramatic decrease in their adhesion potential; 2) the 
absence of a neurological phenotype in Pcdh19β-Geo/β-Geo mice suggests that cells completely 
lacking PCDH19 are largely normal and 3) in vitro experiments where two populations of 
cells expressed the same number but different NC PCDH molecules displayed cell 
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Here we have shown that abnormal cell sorting underlies the unique X-linked inheritance 
pattern of PCDH19-GCE. This provides a platform to investigate how abnormal cell sorting 
leads to seizures, intellectual disability and autism spectrum disorder. A series of 
experiments is described below to identify additional neurological processes which are 
disrupted due to the mosaic expression of Pcdh19 which may contribute to pathology. 
 
5.1 Investigating Connectivity between PCDH19 WT and PCDH19 null 
neurons 
Given the expression of PCDH19 at the synapse (Chapter 2) and the known roles for δ2 
PCDHs in axon guidance and synaptogenesis (Hayashi et al., 2014; Uemura et al., 2007) we 
envisage that synaptic connections between PCDH19 WT and PCDH19 mutant cells will be 
disrupted in PCDH19 heterozygous females contributing to disease. Furthermore, the 
morphology of neurons positioned at boundaries between PCDH19 WT and PCDH19 KO 
cells may be affected.  We hypothesise that abnormal cell sorting of PCDH19 WT and 
PCDH19 KO cells alters neuronal connectivity through disruption of lateral connections 
within the cortex. This can be investigated by generating a Pcdh19-P2A-CRE mouse 
(Pcdh19Cre), permitting the expression of CRE in cells expressing functional PCDH19. 
Pcdh19Cre mice could then be used in two ways to investigate morphology and arborisation 
of PCDH19 neurons. The first approach would cross Pcdh19Cre mice to commercially 
available Brainbow 3.2 mice (Cai et al., 2013), which generate multi-coloured neurons in 
response to Cre recombination which variably activates three membrane-bound fluorophores 
to create a range of colours. This will allow individual PCDH19 expressing neurons to be 
traced even in large groups of PCDH19 positive cells allowing us to test the hypothesis that 
neuronal processes will also be segregated in addition to cell bodies.  Secondly in utero 
electroporation of mouse embryos with a loxP-membrane_tdTomato-loxP-membrane_GFP 
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construct (pCA-mT/mG – Addgene plasmid #26123) will result in mGFP staining only in 
Pcdh19-Cre positive cells while Pcdh19-Cre negative cells will express mtdTomato. 
Comparing Scholl analysis of mGFP neurons in Pcdh19Cre/+ and Pcdh19Cre/β-Geo brains will 
assess any reduction in arborisation formed at the boundaries of PCDH19 WT and PCDH19 
KO cells in the cortex. 
To investigate functional synaptic connectivity between PCDH19 WT and PCDH19 KO 
cells a modified rabies virus (EnvA-delta;G) (DeNardo et al., 2015) can be used to assess 
the degree of monosynaptic transmission. This approach would also utilise the Pcdh19Cre 
mice as the modified rabies virus is expressed in a Cre-dependent fashion, allowing only 
Pcdh19-Cre cells to become competent for infection. Initially a cre-dependent helper AAV 
virus will be injected into the cortex to express TVA-mCherry, which is essential for rabies 
virus infection. 14 days later the rabies-GFP virus will be injected and brains analysed 5 days 
later. This approach marks “starter” cells in yellow and “input” cells in green allowing robust 
identification of cells which have received synaptic inputs. We would expect to see reduced 
connectivity in Pcdh19Cre/β-Geo brains compared to Pcdh19Cre/+ brains. Furthermore, we 
would expect that connectivity when present in Pcdh19Cre/β-Geo brains will be restricted to 
cells within the same patch of Pcdh19-Cre cortex and will not propagate into PCDH19 null 
zones. The same technique could also be applied in vitro on cultured primary neurons from 
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5.2 Is Interneuron Distribution Affected by Mosaic Pcdh19 Expression? 
Inhibitory neurons (interneurons) are responsible for keeping neuronal circuits “in check” 
and maintaining proper firing rates between excitatory neurons. It has been suggested that 
altered inhibition due to interneuron dysfunction is an underlying cause of epilepsy (Bernard 
et al., 2000; Holmes, 1997; Tasker and Dudek, 1991).  
Cortical interneurons begin life in the ganglionic eminence and undergo a long range 
tangential migration path which relies on a large number of molecular cues. Physical, genetic 
or chemical disruptions in brain development can impair interneuron function resulting in 
unstable neural circuits, evolving into seizures. Due to the relatively low number of 
interneurons compared to excitatory neurons in the mammalian cortex (approximately 1:3 
(Markram et al., 2004)) it is crucial that they are appropriately distributed to allow correct 
network inhibition.  
 
We have evidence that PCDH19 is expressed in both interneuron progenitors in the 
ganglionic eminence and tangentially migrating interneurons in the marginal zone of the 
developing cortex (Figure 1-5A). Furthermore, segregation of PCDH19-positive and 
PCDH19-null interneurons is observed in both the ganglionic eminence and marginal zone 
(Figure 1-5B and C). Therefore, we hypothesise that segregation of PCDH19-positive and 
PCDH19-null interneuron precursors during tangential migration leads to abnormal 
distribution of cortical interneurons in the mature brain. In the future it would be interesting 
to test whether the final location of PCDH19-positive interneurons is segregated and whether 
this segregation corresponds with the abnormal cell sorting pattern observed in excitatory 
cells of the cortex. We feel there are two possible presentations of interneuron segregation; 
interneurons will segregate according to PCDH19 expression in excitatory cells, such that 
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PCDH19 expressing interneurons only populate PCDH19 expressing zones of the cortex 
(Figure 2-5, left); alternatively, segregation established during migration of interneurons is 
the determining factor in final distribution and not abnormal cell sorting in cortical excitatory 
cells (Figure 2-5, right). To investigate this, we will utilise the Pcdh19Cre mouse described 
above to specifically label PCDH19 expressing interneurons in a heterozygous brain and see 
where they are finally positioned. We will specifically label PCDH19-Cre positive 
interneurons by in utero electroporation of mT/mG plasmid into the ganglionic eminence of 
Pcdh19Cre/β-Geo embryos. This technique will allow us to trace the lineage of mature 
interneurons expressing PCDH19 throughout development as they will be marked by mGFP 
due to Cre-recombination. Mature brains will be stained for HA to show the cortical cell 
sorting pattern and GFP to reveal the location of PCDH19-Cre positive interneurons.  
If PCDH19-positive interneurons are restricted to PCDH19-positive patches of cortex we 
envisage a disturbance in the distribution of interneurons. We have evidence showing the X-
inactivation ratio in the cortex can be vastly different from the X-inactivation pattern in the 
ganglionic eminence in the same hemisphere which could lead to a situation where there is 
an insufficient number of PCDH19-positive interneurons or PCDH19-negative interneurons 
to distribute amongst the appropriate patches in cortex. This would result in regions with 
increased excitation due to lack of interneurons. Alternatively, if interneuron distribution is 
unaffected it will result in PCDH19 WT interneurons being present in PCDH19 KO patches 
of the cortex and vice versa. As we suggested above, synaptic connections between PCDH19 
WT and PCDH19 KO neurons may be perturbed, therefore inhibitory synapses in these 
regions may be disrupted, again leading to increased excitation.  
 
 














Figure 1-5. PCDH19 is expressed in tangentially migrating cortical interneurons which 
undergo abnormal cell sorting. A) Co-immunostaining of 15.5 dpc HA-FLAG/Y brains reveals 
PCDH19 expression in tangentially migrating cortical interneurons. B) HA and X-gal staining of 
14.5 dpc HA-FLAG/β-Geo brains shows segregation of PCDH19 positive and PCDH19 null cells in 
the ganglionic eminence. C) HA and X-gal staining of 16.5 dpc brains confirms abnormal cell sorting 


























Figure 2-5.  Schematic diagram describing different mechanisms that may lead to abnormal 
interneuron distribution. It is proposed that the final position of interneurons in the mature cortex 
is dictated by either their pre-segregation pattern (left) or selective homing to “PCDH19-like” regions 






Pre-segregated Pattern Selective Homing 
PCDH19KO pyramidal progenitor 
PCDH19KO interneuron progenitor 
PCDH19HA-FLAG pyramidal progenitor 
PCDH19HA-FLAG interneuron progenitor 
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To complement the above experiments investigating the role of PCDH19 in the final 
positioning of interneurons we could generate a floxed Pcdh19 allele (Pcdh19fl) which would 
result in complete loss of PCDH19 in the presence of Cre. Pcdh19fl mice will be crossed 
with Dlx-Cre mice which will lead to the deletion of Pcdh19 in all cortical interneurons. We 
hypothesise that PCDH19 negative interneurons will fail to be positioned correctly in the 
cortex leading to decreased local inhibition of excitatory neurons. Furthermore, Pcdh19fl 
mice could be crossed with Emx1-Cre mice which will delete Pcdh19 from all excitatory 
pyramidal neurons of the cortex. Again we would hypothesise that Pcdh19 positive 
interneurons will fail to be positioned correctly in the cortex. These experiments will 
investigate the importance of PCDH19 expression in both excitatory and inhibitory neurons 
of the cortex and its role in determining the final position of cortical interneurons. They 
could also highlight a role for PCDH19 in dictating specific cell-cell interactions not only 
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5.3 Can Epileptiform Brain Activity be Rescued after Abnormal Cell 
Sorting has Occurred? 
In Chapter 3 we show that deletion of PCDH19 in heterozygous female embryos reverses 
abnormal cell sorting. This experiment was performed in zygotes meaning that Pcdh19 was 
deleted before its initial expression in the developing brain at 9.5dpc and consequently 
before abnormal cell sorting occurs. It would be interesting to investigate whether the 
deletion of Pcdh19 after abnormal cell sorting has begun can rescue the phenotype. 
Furthermore, if PCDH19 is important in forming homotypic interactions during 
synaptogenesis, deletion of Pcdh19 in the postnatal brain may restore some normal neural 
connectivity even though abnormal cell sorting occurred during development. We 
hypothesise that abnormal cell sorting will only be rescued if Pcdh19 is deleted before 
9.5dpc in the mouse brain, but deletion of Pcdh19 in the postnatal brain will rescue abnormal 
synaptic connections that may occur between PCDH19 WT and PCDH19 KO cells. To test 
this, Pcdh19fl mice could be crossed with an inducible global CRE mouse line where Cre is 
activated in the presence of doxycycline (Dox). Dox will then be introduced to pregnant 
female mice at different stages to determine whether deletion of Pcdh19 can rescue abnormal 
cell sorting. Furthermore, Pcdh19fl/β-Geo adult mice could be subject to ECoG analysis to 
assess their level of increased brain activity and then be administered with Dox followed by 
another ECoG analysis. This will determine if deletion of Pcdh19 in the adult brain can 
restore neuronal connections between PCDH19 WT and PCDH19 KO cells returning circuit 
activity to normal.  
The experiments outlined above will provide further insight into how abnormal cell sorting 
ultimately leads to epileptiform brain activity in Pcdh19HA-FLAG/β-Geo mice. This information 
will be critical in understanding the origin of seizures in PCDH19-GCE and the development 
of much needed novel treatments.  
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5.4 Investigating the Combinatorial Activity of Other NC PCDHs In Vivo 
To support our data suggesting that NC PCDHs cooperate to dictate specific cell-cell 
interactions in the developing brain, it would be interesting to investigate whether cell 
sorting occurs with mosaic expression of other NC PCDH members. This experiment is 
particularly challenging as all other PCDHs are autosomal genes, unlike PCDH19 which is 
X-linked, and therefore undergoes X-inactivation generating a mosaic expression pattern. 
One approach to perform this experiment would be to utilise Pcdh19Cre mice as a system 
that can recombine DNA in a manner resembling X-inactivation. This would also require 
the generation of a floxed gene of interest, for example Pcdh10. In order to label PCDH10 
WT and PCDH10 KO cells the floxed allele would be generated using CRISPR-Cas9 
technology in zygotes of mT/mG strain (Muzumdar et al., 2007). This mT/mG strain 
operates in the same way as the above described plasmid where cells express membrane-
GFP in the presence of Cre, while cells are membrane-tdTomato positive in the absence of 
Cre. Mice would be generated that are homozygous for both the mT/mG allele and the 
floxed-PCDH10 allele. These mice could then be crossed with Pcdh19Cre/+ mice to generate 
mosaic expression of PCDH10 WT and PCDH10 KO cells that are labelled with mtdTomato 
and mGFP respectively, allowing easy identification of a cell sorting phenotype (Figure 3-
5). 
Alternatively, PCDH10 KO mouse embryonic stem cells (mESC) that contain a GFP marker 
could be generated and injected into mouse blastocysts. The localisation of PCDH10 KO 
ESCs could be compared to that of PCDH10 WT ESCs in the developing cortex to 
investigate a cell sorting phenotype. Both of the describe techniques could be performed 
with multiple NC PCDHs to further strengthen a combinatorial role in the developing brain 
 


















Figure 3-5. Experimental design to investigate the effect mosaic expression of PCDH10 has on 
cortical cell sorting. Mice will be generated that display mosaic expression of PCDH10 due to Cre 
recombination driven by the X-linked Pcdh19Cre allele. We hypothesis that abnormal cell sorting will 
occur in animals with mosaic PCDH10 expression but normal cell sorting will occur in animals that 
are either complete KO or HET for PCDH10.  
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5.5 Concluding remarks 
This study aimed to understand the cellular and molecular basis of the unique X-linked inheritance 
pattern associated with PCDH19-GCE. 
Our data highlights the ability of PCDH19 to cooperate with other NC PCDHs and dictate adhesion 
specificities. In vivo, the generation of differential adhesion codes caused by mosaic expression of 
PCDH19 leads to abnormal cell sorting, such that PCDH19-positive and PCDH19-null neuronal 
progenitors segregate within the developing cortex. Furthermore, abnormal cell sorting is not present 
in animals completely lacking PCDH19. Our findings suggest that disruption of cellular adhesion 
codes is associated with the unique X-linked inheritance of PCDH19-GCE and that just a single 
difference in PCDH expression is enough to disrupt the complex adhesion codes present in the 
















Immunostaining was performed as described in chapter 3. Additional antibodies used  
goat anti-SOX3 1:300 (R&D Systems, AF2569 and guinea pig anti-CALBINDIN 1:400 
(Synaptic Systems,214004). Images were acquired on a Leica SP5 Confocal microscope.   
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